Squamous cell carcinoma, adenoid
0 0 0 0 0 1 0 3 1 5 8 8 12 17 9 14 4 3 3 0
0 0 0 0 0 0 0 1 0 2 4 5 11 17 10 18 8 10 27 0
Malignant teratoma, intermediate
0 0 0 0 3 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0
0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pineocytoma
0 0 0 0 0 1 0 0 1 1 0 0 0 1 0 0 0 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 3 0 0
Leydig cell tumor, malignant
0 1 1 1 1 5 6 3 3 5 2 6 5 2 3 1 3 0 0 0
0 0 0 0 0 2 2 1 1 2 1 4 4 2 3 1 6 0 0 0
Carcinoma in pleomorphic adenoma
0 0 0 0 1 1 6 10 8 18 16 20 15 18 19 20 14 8 2 1
0 0 0 0 0 0 2 4 3 9 9 14 13 18 21 27 28 28 18 29
Embryonal carcinoma, NOS
32 4 17 241 689 777 646 353 210 113 67 38 26 13 8 3 3 2 0 0
16 1 8 119 373 403 318 155 94 56 38 28 24 13 9 4 6 7 0 0
Plasmacytoma, extramedullary
0 0 1 0 5 6 19 28 42 56 80 100 123 124 125 92 83 32 9 1
0 0 0 0 2 3 9 12 18 28 46 74 114 129 141 124 168 115 81 29
Follicular lymphoma, grade 1
0 0 5 7 19 102 220 373 579 774 970 1104 1119 1164 1142 822 537 259 61 9
0 0 2 3 10 53 108 164 260 387 559 826 1040 1220 1288 1110 1090 933 549 268
Astroblastoma
13 18 11 13 15 17 11 14 10 14 21 14 14 13 10 8 3 0 0 0
6 8 5 6 8 8 5 6 4 7 12 10 13 13 11 10 6 0 0 0
Epithelioid cell melanoma
0 1 1 3 7 8 15 13 24 30 34 53 39 58 51 42 19 16 7 1
0 0 0 1 3 4 7 5 10 15 19 39 36 60 57 56 38 57 63 29
Papillary carcinoma, follicular variant
0 18 57 210 519 865 1010 1257 1259 1216 1190 966 727 621 471 317 137 52 11 1
0 8 27 104 281 449 497 555 566 608 686 723 675 650 531 428 278 187 99 29
Hemangioma, NOS
1 2 0 2 4 5 2 4 5 9 7 11 3 2 0 3 1 1 0 0
0 0 0 0 2 2 0 1 2 4 4 8 2 2 0 4 2 3 0 0
Ependymoma, NOS
223 72 76 54 71 107 99 108 111 111 100 99 76 60 41 27 8 3 1 0
116 34 37 26 38 55 48 47 49 55 57 74 70 62 46 36 16 10 9 0
Epithelioid hemangioendothelioma, malignant
0 0 1 6 6 2 10 13 10 6 13 10 9 7 4 8 4 1 0 0
0 0 0 2 3 1 4 5 4 3 7 7 8 7 4 10 8 3 0 0
Mucinous adenocarcinofibroma
0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0
Dermoid cyst, NOS
1 0 0 0 1 0 0 1 1 0 1 1 1 0 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Hemangiosarcoma
4 2 2 10 29 39 50 50 58 73 83 128 123 159 164 175 133 105 39 8
2 0 0 4 15 20 24 22 26 36 47 95 114 166 185 236 269 378 351 238
Paget disease and intraductal ca.
0 0 0 0 0 3 26 55 76 109 113 139 169 176 165 169 108 68 15 7
0 0 0 0 0 1 12 24 34 54 65 104 157 184 186 228 219 244 135 208
Hepatocellular carcinoma, NOS
11 19 31 31 62 98 167 311 656 1433 2246 2534 2730 2980 3076 2660 1530 688 186 26
5 9 15 15 33 50 82 137 294 717 1295 1896 2537 3123 3470 3592 3105 2478 1675 774
Serous surface papillary carcinoma
0 0 0 1 9 21 30 69 108 188 268 347 417 443 366 347 190 82 18 2
0 0 0 0 4 10 14 30 48 94 154 259 387 464 412 468 385 295 162 59
Inflammatory carcinoma
0 0 0 0 4 31 119 207 296 419 423 429 374 303 280 214 136 89 43 7
0 0 0 0 2 16 58 91 133 209 243 321 347 317 315 289 276 320 387 208
Neuroendocrine carcinoma
0 1 1 16 39 44 80 126 208 343 457 560 636 801 832 732 499 189 56 10
0 0 0 7 21 22 39 55 93 171 263 419 591 839 938 988 1012 680 504 297
Sq. cell carc. in situ with question. stromal invas.
0 0 0 1 7 8 12 9 5 8 3 6 9 4 4 4 3 1 1 0
0 0 0 0 3 4 5 3 2 4 1 4 8 4 4 5 6 3 9 0
Chordoid glioma
0 1 1 0 0 0 0 1 1 0 1 0 0 0 1 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
Teratoma with malig. transformation
0 0 0 2 1 3 2 3 4 1 5 3 4 3 3 0 1 0 0 0
0 0 0 0 0 1 0 1 1 0 2 2 3 3 3 0 2 0 0 0
Sq. cell carcinoma, micro-invasive
0 0 0 17 130 495 620 560 489 362 267 217 214 215 164 95 66 20 4 3
0 0 0 8 70 257 305 247 219 181 153 162 198 225 185 128 133 72 36 89
Leiomyoma, NOS
0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Adenocarcinoma in situ in familial polyp. coli
0 0 1 0 0 3 3 2 2 1 2 1 4 3 3 4 3 0 0 0
0 0 0 0 0 1 1 0 0 0 1 0 3 3 3 5 6 0 0 0
Yolk sac tumor
169 15 26 60 83 91 62 34 26 12 11 5 3 6 3 1 0 0 1 0
88 7 12 29 45 47 30 15 11 6 6 3 2 6 3 1 0 0 9 0
Adenocarcinoma in adenoma. polyposis coli
0 0 0 4 6 13 16 19 15 16 24 11 13 24 16 12 2 1 0 0
0 0 0 1 3 6 7 8 6 8 13 8 12 25 18 16 4 3 0 0
Pineoblastoma
16 13 10 11 10 7 6 6 2 2 4 3 3 2 0 1 2 0 0 0
8 6 4 5 5 3 2 2 0 1 2 2 2 2 0 1 4 0 0 0
Trichilemmocarcinoma
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 29
Refractory anemia
1 1 0 4 2 2 5 3 13 15 31 59 59 106 118 196 218 124 52 6
0 0 0 1 1 1 2 1 5 7 17 44 54 111 133 264 442 446 468 178
Papillary carcinoma in situ
0 0 0 0 6 6 10 10 22 37 36 59 64 93 100 93 55 47 9 3
0 0 0 0 3 3 4 4 9 18 20 44 59 97 112 125 111 169 81 89
Leiomyosarcoma, NOS
4 8 16 35 57 145 239 410 616 830 909 889 883 884 834 727 486 259 103 20
2 3 7 17 30 75 117 181 276 415 524 665 820 926 940 981 986 933 927 595
Spindle cell melanoma, NOS
0 6 6 11 21 34 33 54 58 92 96 122 147 151 143 145 117 68 43 10
0 2 2 5 11 17 16 23 26 46 55 91 136 158 161 195 237 244 387 297
Cavernous hemangioma
2 2 3 1 7 3 7 8 4 4 10 5 2 3 2 3 0 0 0 0
1 0 1 0 3 1 3 3 1 2 5 3 1 3 2 4 0 0 0 0
Ependymoma, anaplastic
46 18 13 6 4 13 3 9 12 7 7 6 3 3 1 0 0 1 0 0
24 8 6 2 2 6 1 3 5 3 4 4 2 3 1 0 0 3 0 0
Papillary carcinoma, NOS
1 13 91 385 1002 1539 2051 2178 2134 1996 1883 1708 1719 1746 1563 1281 852 458 171 36
0 6 44 191 543 799 1009 961 959 999 1085 1278 1597 1830 1763 1730 1729 1650 1539 1072
Papillary microcarcinoma
0 0 1 2 8 28 46 69 87 100 92 94 77 54 31 25 6 2 4 0
0 0 0 0 4 14 22 30 39 50 53 70 71 56 34 33 12 7 36 0
Serous papillary cystic tumor of borderline malignancy (C56.9)
0 0 3 22 70 108 165 194 192 185 149 119 86 89 101 76 28 11 2 0
0 0 1 10 37 56 81 85 86 92 85 89 79 93 113 102 56 39 18 0
ML, small B lymphocytic, NOS
7 9 7 13 27 51 89 145 283 447 662 952 1140 1410 1532 1438 1086 532 166 40
3 4 3 6 14 26 43 64 127 223 381 712 1059 1477 1728 1942 2204 1916 1494 1191
Hepatocellular carcinoma, fibrolamellar
0 1 2 14 20 12 7 10 3 5 7 3 5 6 5 4 2 1 0 0
0 0 0 6 10 6 3 4 1 2 4 2 4 6 5 5 4 3 0 0
Merkel cell carcinoma
0 0 0 0 1 2 4 5 24 39 81 83 127 193 269 330 329 246 109 31
0 0 0 0 0 1 1 2 10 19 46 62 118 202 303 445 667 886 981 923
Clear cell chondrosarcoma
0 0 0 0 3 0 0 1 1 2 1 1 0 0 0 2 0 0 0 0
0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0
Squamous intraepithelial neoplasia, grade III
0 0 14 1141 4045 4939 4082 3034 2349 1702 1151 825 582 506 391 244 146 69 21 3
0 0 6 567 2193 2566 2009 1339 1056 852 663 617 540 530 441 329 296 248 189 89
Mixed germ cell tumor
11 9 44 243 494 551 503 330 199 97 62 23 10 8 5 2 2 0 0 1
5 4 21 120 267 286 247 145 89 48 35 17 9 8 5 2 4 0 0 29
Sclerosing sweat duct carcinoma
0 0 1 0 1 2 2 3 3 5 12 17 16 17 12 14 12 9 6 0
0 0 0 0 0 1 0 1 1 2 6 12 14 17 13 18 24 32 54 0
Adenocarc. in situ in mult. adenomatous polyps
0 0 1 0 0 0 3 1 0 0 3 3 11 4 10 5 5 2 1 1
0 0 0 0 0 0 1 0 0 0 1 2 10 4 11 6 10 7 9 29
Craniopharyngioma
8 10 2 5 2 4 6 0 8 7 11 5 5 3 0 4 4 1 0 0
4 4 0 2 1 2 2 0 3 3 6 3 4 3 0 5 8 3 0 0
Adenocarcinoma in mult. adenomatous polyps
0 0 0 0 2 3 4 1 3 11 16 8 19 27 17 24 14 5 0 1
0 0 0 0 1 1 1 0 1 5 9 5 17 28 19 32 28 18 0 29
Spindle cell melanoma, type A
0 0 0 3 1 1 2 0 4 3 3 6 7 6 3 5 1 3 0 0
0 0 0 1 0 0 0 0 1 1 1 4 6 6 3 6 2 10 0 0
Verrucous carcinoma, NOS
0 0 0 1 3 10 26 32 50 75 115 158 209 210 235 195 225 116 48 13
0 0 0 0 1 5 12 14 22 37 66 118 194 220 265 263 456 417 432 387
Endometrial stromal sarcoma
0 0 0 4 5 17 40 64 104 145 114 95 79 80 78 62 36 21 7 1
0 0 0 1 2 8 19 28 46 72 65 71 73 83 88 83 73 75 63 29
Epithelioid leiomyosarcoma
0 1 1 6 4 8 9 19 26 48 46 56 60 56 66 38 32 18 2 0
0 0 0 2 2 4 4 8 11 24 26 41 55 58 74 51 64 64 18 0
Papillary ependymoma
2 0 1 0 0 1 0 0 0 1 2 0 0 1 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0
Papillary carcinoma, oxyphilic cell
0 0 0 1 0 1 2 1 1 3 0 1 1 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0
Venous hemangioma
0 0 0 0 0 1 0 2 0 1 0 1 0 0 0 0 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0
ML, large B-cell, diffuse, immunoblastic, NOS
5 11 11 37 70 123 251 323 330 301 276 332 401 476 514 477 332 185 40 17
2 5 5 18 37 63 123 142 148 150 159 248 372 498 579 644 673 666 360 506
Neurofibroma, NOS
1 0 1 0 4 2 0 5 0 3 3 1 3 1 1 1 0 0 0 0
0 0 0 0 2 1 0 2 0 1 1 0 2 1 1 1 0 0 0 0
Neurofibromatosis, NOS
7 10 6 1 1 0 0 1 2 0 0 0 0 0 0 0 0 0 0 0
3 4 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Glioma, malignant
288 315 197 96 83 108 129 150 138 149 186 200 221 269 274 259 239 135 30 4
150 153 96 47 45 56 63 66 62 74 107 149 205 281 309 349 485 486 270 119
ML, lymphoplasmacytic
0 0 2 3 5 8 15 25 49 62 101 125 146 173 181 193 159 80 28 6
0 0 0 1 2 4 7 11 22 31 58 93 135 181 204 260 322 288 252 178
Hepatocellular carcinoma, scirrhous
0 0 0 0 0 0 0 0 0 2 2 1 0 1 1 1 1 0 0 0
0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 2 0 0 0
Oxyphilic adenocarcinoma
0 0 3 8 15 51 51 116 113 141 165 135 148 167 145 140 89 57 10 3
0 0 1 3 8 26 25 51 50 70 95 101 137 175 163 189 180 205 90 89
Malignant peripheral nerve sheath tumor
5 9 26 40 53 53 48 54 71 42 59 49 54 38 47 44 26 22 3 2
2 4 12 19 28 27 23 23 31 21 34 36 50 39 53 59 52 79 27 59
Papillary cystadenocarcinoma, NOS
0 0 0 4 18 19 33 45 65 114 162 182 172 141 144 105 60 36 5 4
0 0 0 1 9 9 16 19 29 57 93 136 159 147 162 141 121 129 45 119
Dedifferentiated chondrosarcoma
0 0 0 0 0 0 0 0 0 5 6 5 1 4 4 5 9 0 0 0
0 0 0 0 0 0 0 0 0 2 3 3 0 4 4 6 18 0 0 0
Squamous cell carcinoma with horn formation
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Chondroblastoma, malignant
0 0 5 4 2 3 2 1 1 0 0 1 0 0 1 0 0 0 0 0
0 0 2 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Eccrine papillary adenocarcinoma
0 0 0 0 0 0 0 3 0 3 2 0 0 0 1 1 0 0 0 0
0 0 0 0 0 0 0 1 0 1 1 0 0 0 1 1 0 0 0 0
Fibrosarcoma, NOS
18 13 27 45 57 67 73 78 71 78 98 90 119 101 102 106 78 44 8 1
9 6 13 22 30 34 35 34 31 39 56 67 110 105 115 143 158 158 72 29
Myxopapillary ependymoma
0 4 3 6 5 14 12 9 9 15 12 12 0 1 6 2 0 0 0 0
0 1 1 2 2 7 5 3 4 7 6 8 0 1 6 2 0 0 0 0
Adamantinomatous craniopharyngioma
5 6 3 1 1 1 0 2 3 6 3 3 1 0 0 1 0 1 0 0
2 2 1 0 0 0 0 0 1 3 1 2 0 0 0 1 0 3 0 0
Peripheral neuroectodermal tumor
6 12 13 26 11 14 14 15 10 6 7 7 6 7 3 6 1 4 0 0
3 5 6 12 5 7 6 6 4 3 4 5 5 7 3 8 2 14 0 0
Sertoli cell carcinoma
0 1 1 4 3 1 2 1 4 2 3 0 2 0 2 1 0 1 0 0
0 0 0 1 1 0 0 0 1 1 1 0 1 0 2 1 0 3 0 0
Refractory anemia with sideroblasts
0 0 0 0 0 2 4 8 8 9 22 39 43 70 101 160 188 89 40 4
0 0 0 0 0 1 1 3 3 4 12 29 39 73 113 216 381 320 360 119
Follicular lymphoma, grade 3
1 3 4 7 11 40 68 109 187 257 307 404 415 464 455 375 278 154 33 5
0 1 1 3 5 20 33 48 84 128 177 302 385 486 513 506 564 554 297 148
Papillary squamous cell carcinoma, non-invasive
0 0 1 0 1 1 3 2 4 6 15 11 14 12 14 11 9 2 0 0
0 0 0 0 0 0 1 0 1 3 8 8 13 12 15 14 18 7 0 0
Endometrial stromal sarcoma, low grade
0 0 0 0 1 3 12 19 34 62 39 13 8 5 6 4 4 3 0 0
0 0 0 0 0 1 5 8 15 31 22 9 7 5 6 5 8 10 0 0
Dysgerminoma
0 15 47 143 135 186 138 84 52 61 51 22 21 10 7 11 3 1 0 0
0 7 23 71 73 96 67 37 23 30 29 16 19 10 7 14 6 3 0 0
Spindle cell melanoma, type B
0 0 2 3 7 7 25 14 26 43 59 58 56 52 65 30 27 8 5 0
0 0 0 1 3 3 12 6 11 21 34 43 52 54 73 40 54 28 45 0
Papillary squamous cell carcinoma
0 0 0 0 4 6 18 15 32 58 72 75 107 124 89 83 66 33 21 6
0 0 0 0 2 3 8 6 14 29 41 56 99 129 100 112 133 118 189 178
Papillary carcinoma, encapsulated
0 0 0 2 3 8 8 20 14 17 13 8 7 7 2 2 0 0 0 0
0 0 0 0 1 4 3 8 6 8 7 5 6 7 2 2 0 0 0 0
Fibrillary astrocytoma
41 37 34 24 41 55 83 58 58 49 54 45 58 64 48 23 8 5 0 0
21 17 16 11 22 28 40 25 26 24 31 33 53 67 54 31 16 18 0 0
Mal. melanoma in giant pigmented nevus
5 0 3 2 8 4 14 19 26 22 23 24 11 13 10 7 2 2 0 0
2 0 1 0 4 2 6 8 11 11 13 17 10 13 11 9 4 7 0 0
Melanotic neurofibroma
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gliomatosis cerebri
1 1 2 0 1 2 2 1 1 2 2 2 2 7 7 4 5 0 0 0
0 0 0 0 0 1 0 0 0 1 1 1 1 7 7 5 10 0 0 0
Hepatocellular carcinoma, spindle cell variant
0 0 0 0 0 0 0 0 0 1 0 1 1 1 0 2 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0
Follicular adenocarcinoma, NOS
0 3 26 76 173 278 363 391 402 398 355 324 328 312 290 225 134 76 21 4
0 1 12 37 93 144 178 172 180 199 204 242 304 327 327 303 271 273 189 119
Papillary cystadenoma, borderline malignancy (C56.9)
0 0 0 3 5 6 7 8 12 7 10 9 2 7 2 1 0 0 0 0
0 0 0 1 2 3 3 3 5 3 5 6 1 7 2 1 0 0 0 0
Mesonephroma, malignant
0 0 1 2 5 4 3 2 8 21 29 20 18 9 11 10 3 1 0 0
0 0 0 0 2 2 1 0 3 10 16 14 16 9 12 13 6 3 0 0
Atypical carcinoid tumor
0 0 0 0 0 0 3 2 6 10 11 8 8 18 13 8 7 4 0 0
0 0 0 0 0 0 1 0 2 5 6 5 7 18 14 10 14 14 0 0
Cholangiocarcinoma
0 0 1 2 5 17 21 77 125 192 287 407 453 601 694 748 673 412 174 46
0 0 0 0 2 8 10 34 56 96 165 304 421 629 782 1010 1366 1484 1566 1370
Prolymphocytic leukemia, NOS
0 0 0 3 3 1 1 1 5 7 12 20 35 44 41 58 34 23 17 1
0 0 0 1 1 0 0 0 2 3 6 14 32 46 46 78 69 82 153 29
Lobular carcinoma in situ
0 0 0 2 3 20 99 417 1397 2452 2168 1389 1049 834 550 344 187 75 11 4
0 0 0 0 1 10 48 184 628 1227 1250 1039 974 874 620 464 379 270 99 119
Lobular carcinoma, NOS
0 0 1 0 6 56 207 693 1870 3327 3696 3809 4175 4585 4534 4001 2824 1514 537 104
0 0 0 0 3 29 101 306 840 1665 2131 2851 3880 4805 5115 5403 5732 5454 4836 3097
Fibromyxosarcoma
2 2 8 6 9 14 17 17 27 30 25 21 18 32 22 24 13 8 3 2
1 0 3 2 4 7 8 7 12 15 14 15 16 33 24 32 26 28 27 59
Myxoid chondrosarcoma
0 1 4 3 2 10 16 14 20 20 21 12 18 22 14 12 3 9 0 0
0 0 1 1 1 5 7 6 8 10 12 8 16 23 15 16 6 32 0 0
Eccrine poroma, malignant
0 0 0 0 1 1 1 0 2 3 6 2 3 7 4 7 13 4 4 1
0 0 0 0 0 0 0 0 0 1 3 1 2 7 4 9 26 14 36 29
Papillary craniopharyngioma
0 0 0 0 1 0 2 0 2 0 2 1 1 0 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0
Askin tumor
0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Parosteal osteosarcoma
0 1 15 18 24 15 15 13 4 2 4 2 4 1 1 0 0 1 0 0
0 0 7 8 13 7 7 5 1 1 2 1 3 1 1 0 0 3 0 0
Adenocarcinoma in situ in adenomatous polyp
0 0 0 3 6 13 32 68 154 269 640 795 1172 1388 1370 1230 736 360 92 11
0 0 0 1 3 6 15 30 69 134 369 595 1089 1454 1545 1661 1493 1296 828 327
Marginal zone B-cell lymphoma, NOS
0 1 4 7 17 38 55 105 147 279 328 395 394 478 592 541 418 257 58 11
0 0 1 3 9 19 27 46 66 139 189 295 366 501 667 730 848 925 522 327
Refractory anemia with excess blasts
0 3 1 3 1 0 3 9 15 26 37 51 78 92 140 184 184 105 27 4
0 1 0 1 0 0 1 3 6 13 21 38 72 96 157 248 373 378 243 119
Adenocarcinoma in adenomatous polyp
0 0 2 4 14 29 72 172 369 710 1502 2036 2801 3529 3629 3205 2265 1128 347 59
0 0 0 1 7 15 35 75 165 355 866 1524 2603 3698 4094 4328 4597 4063 3124 1757
Seminoma, NOS
0 0 4 81 640 1617 2177 2092 1585 940 523 275 150 98 53 37 13 9 3 0
0 0 1 40 347 840 1071 923 712 470 301 205 139 102 59 49 26 32 27 0
Papillary carcinoma, columnar cell
0 0 0 2 1 3 8 10 10 10 10 6 13 9 11 8 4 3 3 1
0 0 0 0 0 1 3 4 4 5 5 4 12 9 12 10 8 10 27 29
Pilocytic astrocytoma
328 318 290 194 114 96 54 48 48 35 31 19 19 12 11 6 3 2 0 0
171 154 141 96 61 49 26 21 21 17 17 14 17 12 12 8 6 7 0 0
Mixed glioma
34 26 24 40 57 91 135 113 138 102 87 70 53 54 24 21 2 5 0 0
17 12 11 19 30 47 66 49 62 51 50 52 49 56 27 28 4 18 0 0
Hepatocellular carcinoma, clear cell type
0 0 1 0 0 0 1 1 0 4 8 8 5 8 4 7 9 3 2 0
0 0 0 0 0 0 0 0 0 2 4 5 4 8 4 9 18 10 18 0
Follicular adenocarcinoma well diff.
0 1 0 9 34 54 61 53 42 52 43 40 27 35 28 20 14 4 2 1
0 0 0 4 18 28 30 23 18 26 24 29 25 36 31 27 28 14 18 29
Mantle cell lymphoma
1 0 0 2 6 7 26 36 89 155 268 325 364 457 458 444 294 143 48 11
0 0 0 0 3 3 12 15 40 77 154 243 338 479 516 599 596 515 432 327
Ganglioneuroma
0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Kupffer cell sarcoma
0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Bile duct cystadenocarcinoma
0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 4 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 5 2 0 0 0
Solid pseudopapillary carcinoma
0 0 0 2 1 1 2 2 3 6 1 4 2 0 0 1 0 0 0 0
0 0 0 0 0 0 0 0 1 3 0 2 1 0 0 1 0 0 0 0
Prolymphocytic leukemia, B-cell type
0 0 0 1 0 0 0 1 1 0 1 4 5 3 4 4 5 4 1 1
0 0 0 0 0 0 0 0 0 0 0 2 4 3 4 5 10 14 9 29
Malignant cystic nephroma
0 0 0 0 0 0 0 1 3 0 1 2 0 1 1 2 0 0 0 0
0 0 0 0 0 0 0 0 1 0 0 1 0 1 1 2 0 0 0 0
Ganglioneuroblastoma
218 46 14 10 6 3 4 1 1 1 1 2 3 3 1 3 0 0 0 0
113 22 6 4 3 1 1 0 0 0 0 1 2 3 1 4 0 0 0 0
Lymphoid leukemia, NOS
14 13 8 11 5 4 8 18 18 48 57 78 78 114 130 133 135 95 46 18
7 6 3 5 2 2 3 7 8 24 32 58 72 119 146 179 274 342 414 536
Infiltrating ductular carcinoma
0 0 0 0 0 1 17 41 52 76 95 112 117 133 96 74 44 35 10 3
0 0 0 0 0 0 8 18 23 38 54 83 108 139 108 99 89 126 90 89
Periosteal fibrosarcoma
0 0 1 1 3 2 2 0 1 1 1 3 2 5 3 0 0 0 0 0
0 0 0 0 1 1 0 0 0 0 0 2 1 5 3 0 0 0 0 0
Periosteal osteosarcoma
0 0 0 4 3 0 2 1 0 1 0 0 0 0 0 0 0 0 0 0
0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Refract. anemia with excess blasts in transformation
0 0 0 0 0 0 1 0 4 1 3 6 9 6 14 18 18 8 0 0
0 0 0 0 0 0 0 0 1 0 1 4 8 6 15 24 36 28 0 0
Osteosarcoma, NOS
17 122 364 386 141 85 78 60 52 62 59 69 86 87 70 86 37 25 8 3
8 59 178 192 76 44 38 26 23 31 34 51 79 91 78 116 75 90 72 89
Adenosarcoma
0 0 1 2 7 8 14 23 34 40 45 44 44 57 38 38 15 10 5 0
0 0 0 0 3 4 6 10 15 20 25 32 40 59 42 51 30 36 45 0
Angiomyosarcoma
0 0 0 1 0 2 2 1 2 0 2 1 4 2 2 2 2 1 0 0
0 0 0 0 0 1 0 0 0 0 1 0 3 2 2 2 4 3 0 0
Subependymoma
0 1 0 1 1 2 3 3 5 9 3 7 3 1 1 1 1 1 0 0
0 0 0 0 0 1 1 1 2 4 1 5 2 1 1 1 2 3 0 0
Seminoma, anaplastic
1 0 0 9 34 105 122 113 84 54 32 19 23 14 7 8 4 1 0 0
0 0 0 4 18 54 60 49 37 27 18 14 21 14 7 10 8 3 0 0
Tubular adenocarcinoma
0 1 0 1 0 4 28 111 354 703 842 766 823 858 801 658 417 156 47 5
0 0 0 0 0 2 13 49 159 351 485 573 764 899 903 888 846 562 423 148
Ovarian stromal tumor, mal.
0 0 0 3 4 3 1 3 4 4 1 2 7 0 4 4 0 1 0 0
0 0 0 1 2 1 0 1 1 2 0 1 6 0 4 5 0 3 0 0
Medullary carcinoma with amyloid stroma
0 12 24 22 29 51 71 73 87 76 94 90 84 81 77 54 33 8 3 0
0 5 11 10 15 26 34 32 39 38 54 67 78 84 86 72 66 28 27 0
Burkitt lymphoma, NOS
85 159 145 99 71 95 132 147 147 114 95 87 54 65 73 64 46 29 4 3
44 77 70 49 38 49 64 64 66 57 54 65 50 68 82 86 93 104 36 89
Small cell carcinoma, NOS
5 1 4 14 31 55 89 281 810 1810 3687 6175 8180 9641 9198 7099 3712 1261 253 25
2 0 1 6 16 28 43 124 364 906 2126 4622 7602 10105 10377 9588 7534 4542 2278 744
Acidophil adenoma
0 0 0 0 1 0 1 1 0 0 1 0 0 1 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Alveolar rhabdomyosarcoma
62 57 60 68 30 13 11 10 7 5 3 7 7 3 1 5 2 1 1 0
32 27 29 33 16 6 5 4 3 2 1 5 6 3 1 6 4 3 9 0
Follicular adenocarcinoma trabecular
0 0 0 3 6 9 10 8 16 13 20 16 12 9 11 5 0 2 2 0
0 0 0 1 3 4 4 3 7 6 11 11 11 9 12 6 0 7 18 0
Hepatocellular carcinoma, pleomorphic type
0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Meningioma, NOS
2 3 3 6 14 39 75 136 205 296 351 407 387 386 461 466 466 361 138 49
1 1 1 2 7 20 36 60 92 148 202 304 359 404 520 629 945 1300 1242 1459
Mycosis fungoides
2 7 10 21 42 80 115 179 223 300 325 380 393 416 398 286 224 98 26 8
1 3 4 10 22 41 56 79 100 150 187 284 365 436 449 386 454 353 234 238
Hodgkin granuloma [obs]
0 0 1 0 4 1 5 2 2 2 1 6 0 2 4 3 3 0 0 0
0 0 0 0 2 0 2 0 0 1 0 4 0 2 4 4 6 0 0 0
Klatskin tumor
0 0 0 0 0 2 0 3 1 18 27 26 27 44 64 75 67 55 22 4
0 0 0 0 0 1 0 1 0 9 15 19 25 46 72 101 135 198 198 119
Intraductal papillary-mucinous carcinoma, non-inv.
0 0 0 0 0 0 0 1 0 1 4 5 5 5 5 11 4 1 0 0
0 0 0 0 0 0 0 0 0 0 2 3 4 5 5 14 8 3 0 0
Meningiomatosis, NOS
0 0 1 1 0 0 0 0 2 3 2 3 2 6 5 6 2 6 1 0
0 0 0 0 0 0 0 0 0 1 1 2 1 6 5 8 4 21 9 0
Acidophil carcinoma
1 1 0 0 0 0 2 1 2 0 1 0 0 1 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0
Intraductal papillary-mucinous carcinoma, invasive
0 0 0 0 0 0 0 0 2 2 1 3 6 10 7 4 3 0 0 0
0 0 0 0 0 0 0 0 0 1 0 2 5 10 7 5 6 0 0 0
Prolymphocytic leukemia, T-cell type
0 0 0 0 0 0 0 1 1 4 5 5 4 6 10 4 4 6 1 0
0 0 0 0 0 0 0 0 0 2 2 3 3 6 11 5 8 21 9 0
Intraductal and lobular in situ carcinoma
0 0 0 0 0 4 25 83 304 525 530 380 298 261 240 156 82 31 9 2
0 0 0 0 0 2 12 36 136 262 305 284 276 273 270 210 166 111 81 59
Meningioma, malignant
4 4 3 8 5 11 25 36 48 55 74 95 97 100 135 106 63 28 18 4
2 1 1 3 2 5 12 15 21 27 42 71 90 104 152 143 127 100 162 119
Infiltrating duct and lobular carcinoma
0 0 0 0 4 46 264 716 1619 2673 2839 2723 2673 2645 2521 2154 1435 652 190 42
0 0 0 0 2 23 129 316 727 1338 1637 2038 2484 2772 2844 2909 2912 2348 1711 1250
Cystadenocarcinoma, NOS
0 0 0 5 7 6 28 32 70 79 114 138 137 132 110 110 92 60 34 6
0 0 0 2 3 3 13 14 31 39 65 103 127 138 124 148 186 216 306 178
Fascial fibrosarcoma
1 0 1 1 1 2 3 4 2 2 5 5 6 3 3 2 1 2 2 0
0 0 0 0 0 1 1 1 0 1 2 3 5 3 3 2 2 7 18 0
High grade surface osteosarcoma
0 0 0 0 0 0 1 0 1 0 0 0 0 1 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Spermatocytic seminoma
0 0 0 1 4 8 10 11 9 16 12 8 12 13 6 11 8 2 1 1
0 0 0 0 2 4 4 4 4 8 6 5 11 13 6 14 16 7 9 29
Refractory cytopenia with multilineage dysplasia
1 1 0 1 1 0 2 3 5 6 9 20 35 37 54 69 71 35 9 1
0 0 0 0 0 0 0 1 2 3 5 14 32 38 60 93 144 126 81 29
Sarcoma, NOS
30 20 51 57 78 99 92 137 155 173 229 269 294 319 313 328 298 190 77 26
15 9 24 28 42 51 45 60 69 86 132 201 273 334 353 443 604 684 693 774
Chondrosarcoma, NOS
2 2 25 64 72 114 148 132 158 186 178 166 192 155 160 119 69 44 13 4
1 0 12 31 39 59 72 58 71 93 102 124 178 162 180 160 140 158 117 119
Myosarcoma
3 0 1 0 2 2 0 2 3 4 4 3 4 3 4 4 1 3 1 0
1 0 0 0 1 1 0 0 1 2 2 2 3 3 4 5 2 10 9 0
Supependymal giant cell astrocytoma
2 5 5 2 4 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Chondroblastic osteosarcoma
3 7 40 56 33 17 15 12 9 8 8 6 7 4 5 3 3 1 2 0
1 3 19 27 17 8 7 5 4 4 4 4 6 4 5 4 6 3 18 0
Carcinofibroma
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0
Precursor cell lymphoblastic lymphoma, NOS
67 85 91 87 76 75 81 51 38 40 27 40 44 43 46 36 33 13 4 0
34 41 44 43 41 38 39 22 17 20 15 29 40 45 51 48 66 46 36 0
Androblastoma, malignant
0 0 3 2 2 1 0 0 0 3 0 2 1 0 1 0 1 0 0 0
0 0 1 0 1 0 0 0 0 1 0 1 0 0 1 0 2 0 0 0
Mixed medullary-follicular carcinoma
0 0 0 0 0 0 0 1 1 1 0 2 0 0 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0
Mesothelioma, malignant
1 0 0 6 8 17 33 48 90 161 268 409 559 740 879 851 623 271 80 8
0 0 0 2 4 8 16 21 40 80 154 306 519 775 991 1149 1264 976 720 238
Oat cell carcinoma
0 0 0 1 0 9 24 85 335 741 1512 2475 3233 3587 2946 1832 852 243 48 3
0 0 0 0 0 4 11 37 150 370 871 1852 3004 3759 3323 2474 1729 875 432 89
Rhabdomyosarcoma with ganglionic differentiation
2 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Polar spongioblastoma
1 0 0 3 0 2 0 0 2 0 2 1 1 0 0 1 0 0 1 0
0 0 0 1 0 1 0 0 0 0 1 0 0 0 0 1 0 0 9 0
Anaplastic large cell lymphoma, T-cell and Null cell type
9 18 38 45 23 35 58 59 77 58 63 77 68 74 89 65 54 34 15 1
4 8 18 22 12 18 28 26 34 29 36 57 63 77 100 87 109 122 135 29
ML, mixed sm. and lg. cell, diffuse
1 7 9 19 36 54 73 116 178 193 280 378 505 546 644 572 400 226 81 10
0 3 4 9 19 28 35 51 80 96 161 282 469 572 726 772 811 814 729 297
Fetal adenocarcinoma
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Meningothelial meningioma
1 0 1 0 0 4 13 16 30 46 45 35 39 41 31 22 17 10 1 0
0 0 0 0 0 2 6 7 13 23 25 26 36 42 34 29 34 36 9 0
Gangliocytoma
0 0 2 1 2 1 0 0 0 1 0 1 0 0 1 0 0 0 0 0
0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Protoplasmic astrocytoma
8 2 2 6 8 12 15 6 8 4 5 8 7 1 2 2 1 0 0 0
4 0 0 2 4 6 7 2 3 2 2 5 6 1 2 2 2 0 0 0
Hodgkin sarcoma [obs]
0 0 0 0 1 0 0 1 0 4 0 2 2 1 5 5 1 1 0 0
0 0 0 0 0 0 0 0 0 2 0 1 1 1 5 6 2 3 0 0
Granular cell carcinoma
0 0 2 2 2 3 15 19 40 60 76 109 137 123 138 133 81 25 6 0
0 0 0 0 1 1 7 8 17 30 43 81 127 128 155 179 164 90 54 0
Sezary syndrome
0 0 0 1 1 0 1 4 3 5 6 13 12 14 15 15 19 8 1 1
0 0 0 0 0 0 0 1 1 2 3 9 11 14 16 20 38 28 9 29
Precursor cell lymphoblastic leukemia, NOS
2946 1494 866 661 368 288 275 235 207 213 236 230 254 244 243 224 208 124 42 21
1537 725 423 329 199 149 135 103 93 106 136 172 236 255 274 302 422 446 378 625
Islet cell carcinoma
0 1 2 6 11 15 30 35 61 87 98 103 114 116 101 76 20 15 3 1
0 0 0 2 5 7 14 15 27 43 56 77 105 121 113 102 40 54 27 29
Mesenchymoma, malignant
13 10 7 4 7 5 5 5 9 9 9 16 14 18 19 15 11 2 1 0
6 4 3 1 3 2 2 2 4 4 5 11 13 18 21 20 22 7 9 0
Infiltr. duct mixed with other types of carcinoma, in situ
0 0 1 0 1 15 32 131 540 781 781 836 649 590 524 458 275 114 27 2
0 0 0 0 0 7 15 57 242 390 450 625 603 618 591 618 558 410 243 59
Serous cystadenocarcinoma, NOS
0 0 0 5 15 42 62 106 227 417 519 625 752 728 643 502 328 108 36 3
0 0 0 2 8 21 30 46 102 208 299 467 698 763 725 678 665 389 324 89
Choriocarcinoma
1 0 8 94 153 189 137 91 54 57 21 13 9 10 5 2 3 0 1 0
0 0 3 46 82 98 67 40 24 28 12 9 8 10 5 2 6 0 9 0
Infiltr. duct mixed with other types of carcinoma
0 0 0 0 1 12 30 85 192 339 314 345 366 310 314 324 229 120 52 11
0 0 0 0 0 6 14 37 86 169 181 258 340 324 354 437 464 432 468 327
Infantile fibrosarcoma
50 3 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
26 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0
Intratubular malignant germ cells
1 0 3 2 3 6 3 4 2 1 1 0 0 0 0 1 0 0 0 0
0 0 1 0 1 3 1 1 0 0 0 0 0 0 0 1 0 0 0 0
Medullary carcinoma, NOS
1 1 12 5 32 189 461 699 869 1003 939 837 741 653 514 357 227 125 38 5
0 0 5 2 17 98 226 308 390 502 541 626 688 684 579 482 460 450 342 148
Juxtacortical chondrosarcoma
0 0 3 0 1 1 1 2 1 1 1 2 0 0 2 1 1 0 0 0
0 0 1 0 0 0 0 0 0 0 0 1 0 0 2 1 2 0 0 0
Germinoma
4 25 87 117 111 86 70 69 51 41 19 15 9 7 3 4 1 0 0 0
2 12 42 58 60 44 34 30 22 20 10 11 8 7 3 5 2 0 0 0
Myelodysplastic syndr. with 5q deletion syndrome
0 0 0 0 0 1 0 0 1 1 4 3 9 11 15 24 25 15 3 3
0 0 0 0 0 0 0 0 0 0 2 2 8 11 16 32 50 54 27 89
Spindle cell sarcoma
4 9 8 18 27 25 35 42 64 50 97 110 96 94 107 125 85 53 17 5
2 4 3 8 14 12 17 18 28 25 55 82 89 98 120 168 172 190 153 148
Fibroblastic osteosarcoma
0 4 15 19 16 11 6 5 6 12 5 7 4 4 4 2 0 1 0 0
0 1 7 9 8 5 2 2 2 6 2 5 3 4 4 2 0 3 0 0
Stromal sarcoma, NOS
0 0 1 0 2 2 4 12 18 26 23 21 20 19 17 19 7 7 4 1
0 0 0 0 1 1 1 5 8 13 13 15 18 19 19 25 14 25 36 29
Myxoid leiomyosarcoma
0 0 0 1 0 2 4 5 11 13 16 9 7 13 9 6 1 3 1 0
0 0 0 0 0 1 1 2 4 6 9 6 6 13 10 8 2 10 9 0
Sertoli-Leydig cell tumor, poorly differentiated
0 0 1 11 6 2 2 2 1 0 3 4 1 1 3 3 3 0 0 0
0 0 0 5 3 1 0 0 0 0 1 2 0 1 3 4 6 0 0 0
Mixed medullary-papillary carcinoma
0 0 0 1 1 0 1 1 3 6 1 0 6 2 0 0 0 1 0 0
0 0 0 0 0 0 0 0 1 3 0 0 5 2 0 0 0 3 0 0
Precursor B-cell lymphoblastic lymphoma
10 10 12 6 5 0 3 1 1 0 0 5 3 0 1 0 0 2 0 0
5 4 5 2 2 0 1 0 0 0 0 3 2 0 1 0 0 7 0 0
Splenic marginal zone B-cell lymphoma
0 0 0 0 0 0 0 3 4 13 18 25 25 27 26 37 27 11 4 0
0 0 0 0 0 0 0 1 1 6 10 18 23 28 29 49 54 39 36 0
Acute monocytic leukemia
83 20 28 43 38 48 42 55 74 96 115 125 160 194 188 219 166 99 33 7
43 9 13 21 20 24 20 24 33 48 66 93 148 203 212 295 336 356 297 208
Small cell carcinoma, fusiform cell
0 0 0 0 0 0 0 0 2 4 8 13 12 20 14 4 5 2 0 0
0 0 0 0 0 0 0 0 0 2 4 9 11 20 15 5 10 7 0 0
Pleomorphic xanthoastrocytoma
3 6 20 20 12 7 9 3 4 4 4 3 2 3 1 0 0 0 0 0
1 2 9 9 6 3 4 1 1 2 2 2 1 3 1 0 0 0 0 0
Fibrous mesothelioma, malignant
0 0 0 0 0 0 3 9 11 12 25 26 57 84 86 94 64 22 8 0
0 0 0 0 0 0 1 3 4 6 14 19 52 88 97 126 129 79 72 0
Adenoid cystic carcinoma
0 0 6 15 43 75 126 199 245 313 374 368 367 361 373 249 176 113 29 9
0 0 2 7 23 38 62 87 110 156 215 275 341 378 420 336 357 407 261 268
Chronic myeloproliferative disease, NOS
2 0 0 2 2 3 6 14 14 36 40 41 59 80 97 129 116 60 21 5
1 0 0 0 1 1 2 6 6 18 23 30 54 83 109 174 235 216 189 148
Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)
0 0 0 0 0 0 0 1 0 2 0 1 0 1 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0
Giant cell and spindle cell carcinoma
0 0 0 1 0 1 2 8 5 18 28 28 31 30 38 24 18 14 3 1
0 0 0 0 0 0 0 3 2 9 16 20 28 31 42 32 36 50 27 29
Gemistocytic astrocytoma
4 2 2 2 9 21 50 55 53 47 41 34 40 44 36 22 8 3 0 0
2 0 0 0 4 10 24 24 23 23 23 25 37 46 40 29 16 10 0 0
Fibrous meningioma
0 0 0 0 1 1 10 5 12 16 23 24 14 19 9 10 5 2 0 0
0 0 0 0 0 0 4 2 5 8 13 17 13 19 10 13 10 7 0 0
Mature T-cell lymphoma, NOS
9 11 15 14 22 27 39 62 72 87 97 122 147 144 160 133 132 61 17 5
4 5 7 6 11 14 19 27 32 43 55 91 136 150 180 179 267 219 153 148
Hodgkin lymphoma, nodular sclerosis, NOS
12 96 498 1449 2094 2085 1601 1110 776 543 433 378 297 322 247 208 123 58 22 6
6 46 243 721 1135 1083 788 490 348 271 249 282 276 337 278 280 249 208 198 178
Ameloblastic odontosarcoma
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Precursor B-cell lymphoblastic leukemia
351 150 88 69 37 31 31 31 29 35 35 38 27 29 25 19 5 9 0 0
183 72 43 34 20 16 15 13 13 17 20 28 25 30 28 25 10 32 0 0
Solitary fibrous tumor
0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Serous cystadenoma, borderline malignancy (C56.9)
0 0 1 20 38 75 80 114 131 115 99 82 67 75 63 43 21 11 6 0
0 0 0 9 20 38 39 50 58 57 57 61 62 78 71 58 42 39 54 0
Hodgkin lymphoma, NOS
5 19 58 174 302 314 269 248 210 188 194 191 206 215 224 201 144 80 23 4
2 9 28 86 163 163 132 109 94 94 111 142 191 225 252 271 292 288 207 119
Insulinoma, malignant
0 0 0 0 2 1 2 2 5 0 4 3 1 3 7 5 3 0 1 0
0 0 0 0 1 0 0 0 2 0 2 2 0 3 7 6 6 0 9 0
Embryonal sarcoma
7 7 6 6 2 1 3 0 0 0 0 0 1 1 0 0 0 1 0 0
3 3 2 2 1 0 1 0 0 0 0 0 0 1 0 0 0 3 0 0
B-cell chr. lymph. leuk./small lymphocytic lymphoma
3 0 1 2 5 14 75 179 459 951 1816 2761 3696 4528 5044 4786 3845 2399 1013 292
1 0 0 0 2 7 36 79 206 476 1047 2066 3435 4746 5690 6464 7804 8642 9122 8697
Choriocarcinoma combined w/ other germ cell elements
0 1 5 60 142 149 101 47 30 19 7 5 1 2 0 0 0 0 0 0
0 0 2 29 77 77 49 20 13 9 4 3 0 2 0 0 0 0 0 0
Infiltrating lobular mixed with other types of carc.
0 0 0 0 0 0 2 3 29 49 67 62 87 82 53 62 28 18 12 2
0 0 0 0 0 0 0 1 13 24 38 46 80 85 59 83 56 64 108 59
Solitary fibrous tumor, malignant
0 0 0 0 0 2 1 3 2 6 4 8 13 4 7 3 4 1 0 0
0 0 0 0 0 1 0 1 0 3 2 5 12 4 7 4 8 3 0 0
Cerebellar sarcoma, NOS
1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
Germ cell tumor, nonseminomatous
0 0 2 14 23 25 17 18 5 4 0 0 0 0 0 0 0 0 0 0
0 0 0 6 12 12 8 7 2 2 0 0 0 0 0 0 0 0 0 0
Therapy-related myelodysplastic syndrome, NOS
2 0 0 2 0 2 1 5 3 5 5 12 10 6 13 20 10 5 3 0
1 0 0 0 0 1 0 2 1 2 2 8 9 6 14 27 20 18 27 0
Giant cell sarcoma
1 2 3 3 4 6 6 14 16 25 26 42 36 47 41 42 32 28 11 3
0 0 1 1 2 3 2 6 7 12 14 31 33 49 46 56 64 100 99 89
Skin appendage carcinoma
0 0 3 4 7 6 14 19 21 41 41 46 44 54 67 58 51 23 8 1
0 0 1 1 3 3 6 8 9 20 23 34 40 56 75 78 103 82 72 29
Gastrointestinal stromal sarcoma
0 1 1 4 8 18 27 41 74 124 144 169 148 144 160 165 126 54 20 3
0 0 0 1 4 9 13 18 33 62 83 126 137 150 180 222 255 194 180 89
Telangiectatic osteosarcoma
2 5 14 10 7 3 3 1 2 0 2 1 0 2 1 0 3 0 0 0
1 2 6 4 3 1 1 0 0 0 1 0 0 2 1 0 6 0 0 0
Epithel. mesothelioma, mal.
0 0 0 1 2 5 5 11 21 57 82 151 173 189 210 224 140 55 7 3
0 0 0 0 1 2 2 4 9 28 47 113 160 198 236 302 284 198 63 89
Precursor T-cell lymphoblastic lymphoma
10 14 14 13 11 10 10 4 9 15 3 4 5 1 5 2 0 1 0 1
5 6 6 6 5 5 4 1 4 7 1 2 4 1 5 2 0 3 0 29
Cribriform carcinoma in situ
0 0 0 0 1 3 10 76 273 404 499 435 378 325 323 269 153 61 13 4
0 0 0 0 0 1 4 33 122 202 287 325 351 340 364 363 310 219 117 119
Gynandroblastoma, malignant
0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0
Desmoplastic infantile astrocytoma
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cribriform carcinoma
0 1 0 0 2 3 12 22 41 74 74 74 89 110 128 150 88 37 14 6
0 0 0 0 1 1 5 9 18 37 42 55 82 115 144 202 178 133 126 178
Small cell carcinoma, intermediate cell
0 0 0 0 0 1 3 10 18 54 125 185 263 343 277 238 124 34 3 1
0 0 0 0 0 0 1 4 8 27 72 138 244 359 312 321 251 122 27 29
Lymphangiosarcoma
0 0 1 1 0 0 1 1 1 3 2 4 2 2 8 5 7 2 1 0
0 0 0 0 0 0 0 0 0 1 1 2 1 2 9 6 14 7 9 0
Myelosclerosis with myeloid metaplasia
1 0 0 0 0 2 3 7 10 15 30 34 39 60 58 80 69 28 5 1
0 0 0 0 0 1 1 3 4 7 17 25 36 62 65 108 140 100 45 29
Hepatosplenic gamma-delta cell lymphoma
0 0 1 2 4 1 4 3 2 1 1 0 2 2 0 1 0 0 0 0
0 0 0 0 2 0 1 1 0 0 0 0 1 2 0 1 0 0 0 0
Thymoma, malignant, NOS
1 3 4 6 22 32 39 56 72 104 94 122 106 114 84 68 34 15 1 0
0 1 1 2 11 16 19 24 32 52 54 91 98 119 94 91 69 54 9 0
Follicular carcinoma, minimally invasive
0 0 2 7 14 15 25 28 40 44 33 24 15 13 16 9 3 4 0 0
0 0 0 3 7 7 12 12 17 22 19 17 13 13 18 12 6 14 0 0
Ameloblastic fibrosarcoma
0 0 0 1 1 0 1 0 0 0 0 0 0 1 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0
Psammomatous meningioma
0 0 0 0 0 0 4 5 4 14 9 22 17 14 16 18 11 3 1 0
0 0 0 0 0 0 1 2 1 7 5 16 15 14 18 24 22 10 9 0
Giant cell carcinoma
0 0 0 0 1 1 4 14 28 82 98 125 155 180 165 128 73 20 9 1
0 0 0 0 0 0 1 6 12 41 56 93 144 188 186 172 148 72 81 29
Chromophobe adenoma
0 0 0 0 0 0 1 3 0 3 3 3 3 2 1 1 0 0 0 0
0 0 0 0 0 0 0 1 0 1 1 2 2 2 1 1 0 0 0 0
Embryonal rhabdomyosarcoma
254 170 85 107 40 21 19 13 14 7 4 13 8 9 6 2 4 1 0 1
132 82 41 53 21 10 9 5 6 3 2 9 7 9 6 2 8 3 0 29
Hodgkin lymphoma, nod. scler., cellular phase
1 13 20 49 82 65 53 42 38 35 21 27 34 30 13 11 10 6 2 0
0 6 9 24 44 33 26 18 17 17 12 20 31 31 14 14 20 21 18 0
Water-clear cell adenocarcinoma
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Mal. melanoma in junctional nevus
0 0 3 5 28 29 20 29 34 31 51 37 33 23 20 18 14 7 1 0
0 0 1 2 15 15 9 12 15 15 29 27 30 24 22 24 28 25 9 0
Precursor T-cell lymphoblastic leukemia
16 17 29 21 6 9 5 4 7 9 6 1 1 3 2 2 1 1 0 0
8 8 14 10 3 4 2 1 3 4 3 0 0 3 2 2 2 3 0 0
Hodgkin lymphoma, lymphocyte-rich
2 20 44 64 74 86 74 75 67 65 55 54 47 58 38 31 17 8 2 1
1 9 21 31 40 44 36 33 30 32 31 40 43 60 42 41 34 28 18 29
Glucagonoma, malignant
0 0 0 0 0 2 0 3 3 2 5 2 3 7 6 1 1 1 0 0
0 0 0 0 0 1 0 1 1 1 2 1 2 7 6 1 2 3 0 0
Polymorphous low grade adenocarcinoma
0 0 0 2 0 2 0 4 7 14 11 15 8 12 8 8 5 8 1 0
0 0 0 0 0 1 0 1 3 7 6 11 7 12 9 10 10 28 9 0
Chromophobe carcinoma
0 0 1 1 1 2 2 2 1 10 10 5 2 1 12 6 3 0 0 0
0 0 0 0 0 1 0 0 0 5 5 3 1 1 13 8 6 0 0 0
Malignant teratoma, trophoblastic
0 0 0 0 0 4 1 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Olfactory neurogenic tumor
0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Medullary carcinoma with lymphoid stroma
0 0 0 0 2 11 18 45 41 42 42 33 31 25 19 15 7 3 1 1
0 0 0 0 1 5 8 19 18 21 24 24 28 26 21 20 14 10 9 29
Mucoepidermoid carcinoma
3 15 55 77 117 172 196 242 248 325 360 371 385 388 349 272 190 105 38 9
1 7 26 38 63 89 96 106 111 162 207 277 357 406 393 367 385 378 342 268
Small cell sarcoma
0 2 9 15 9 7 10 4 5 5 4 7 3 1 7 3 3 0 0 0
0 0 4 7 4 3 4 1 2 2 2 5 2 1 7 4 6 0 0 0
Osteosarcoma in Paget disease
0 0 1 0 0 0 0 0 0 0 4 0 7 6 12 13 5 1 1 0
0 0 0 0 0 0 0 0 0 0 2 0 6 6 13 17 10 3 9 0
Adenocarcinoma of anal glands
0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0
Dysembryoplastic neuroepithelial tumor
2 6 4 5 3 2 4 2 3 2 1 0 0 0 0 0 0 0 0 0
1 2 1 2 1 1 1 0 1 1 0 0 0 0 0 0 0 0 0 0
Mesothelioma, biphasic, malignant
0 0 0 1 0 0 1 2 6 7 10 29 29 41 51 45 36 10 2 0
0 0 0 0 0 0 0 0 2 3 5 21 26 42 57 60 73 36 18 0
Combined small cell carcinoma
0 0 0 0 2 0 1 3 2 20 34 62 83 118 115 86 50 15 1 0
0 0 0 0 1 0 0 1 0 10 19 46 77 123 129 116 101 54 9 0
Granulosa cell tumor, malignant
1 2 3 9 9 25 38 49 75 97 119 94 77 76 49 43 24 11 3 0
0 0 1 4 4 12 18 21 33 48 68 70 71 79 55 58 48 39 27 0
Thymoma, type A, malignant
0 0 0 0 0 0 0 0 1 2 5 2 5 8 2 6 3 2 1 0
0 0 0 0 0 0 0 0 0 1 2 1 4 8 2 8 6 7 9 0
Essential thrombocythemia
1 2 1 3 14 20 24 41 54 81 83 92 108 130 149 194 144 111 29 2
0 0 0 1 7 10 11 18 24 40 47 68 100 136 168 262 292 399 261 59
Intestinal T-cell lymphoma
0 0 0 0 0 1 0 0 0 2 1 3 3 3 2 2 1 2 0 0
0 0 0 0 0 0 0 0 0 1 0 2 2 3 2 2 2 7 0 0
Primary effusion lymphoma
0 0 0 0 0 1 0 1 4 3 3 0 3 1 1 0 0 0 0 0
0 0 0 0 0 0 0 0 1 1 1 0 2 1 1 0 0 0 0 0
Angiomatous meningioma
0 1 1 0 0 1 1 0 3 3 7 9 4 6 3 1 2 0 1 0
0 0 0 0 0 0 0 0 1 1 4 6 3 6 3 1 4 0 9 0
Spindle cell carcinoma
0 1 0 0 0 2 8 18 31 33 46 83 101 118 129 120 85 35 18 1
0 0 0 0 0 1 3 7 13 16 26 62 93 123 145 162 172 126 162 29
Prolactinoma
0 0 5 7 5 8 5 16 10 5 3 1 1 6 0 0 1 0 0 0
0 0 2 3 2 4 2 7 4 2 1 0 0 6 0 0 2 0 0 0
Synovial sarcoma, NOS
2 11 42 49 68 67 50 55 44 33 37 29 23 19 15 18 8 3 0 0
1 5 20 24 36 34 24 24 19 16 21 21 21 19 16 24 16 10 0 0
Mixed cell adenocarcinoma
0 0 0 1 4 3 15 26 50 91 149 181 190 167 150 121 95 28 13 2
0 0 0 0 2 1 7 11 22 45 85 135 176 175 169 163 192 100 117 59
Hodgkin lymphoma, nod. scler., grade 1
4 7 17 35 53 45 61 47 33 21 21 15 20 14 15 14 12 5 2 0
2 3 8 17 28 23 30 20 14 10 12 11 18 14 16 18 24 18 18 0
Precancerous melanosis, NOS
1 0 0 2 6 5 9 8 11 4 9 9 10 17 4 8 2 3 2 0
0 0 0 0 3 2 4 3 4 2 5 6 9 17 4 10 4 10 18 0
Astrocytoma, NOS
297 325 328 291 355 467 536 535 527 511 602 673 689 801 636 493 245 83 32 4
155 157 160 144 192 242 263 236 236 255 347 503 640 839 717 665 497 299 288 119
Adenoma, NOS
0 1 2 3 8 13 15 13 23 30 25 26 13 29 15 13 18 8 2 1
0 0 0 1 4 6 7 5 10 15 14 19 12 30 16 17 36 28 18 29
Mal. melanoma in precan. melanosis
0 0 0 1 1 4 3 2 2 2 1 3 2 1 1 4 3 1 0 0
0 0 0 0 0 2 1 0 0 1 0 2 1 1 1 5 6 3 0 0
Clear cell adenocarcinoma, NOS
2 5 5 30 61 124 272 544 1178 1802 2420 3070 3087 3098 2822 2134 1232 517 115 17
1 2 2 14 33 64 133 240 529 902 1395 2298 2869 3247 3183 2882 2500 1862 1035 506
Hodgkin lymphoma, mixed cellularity, NOS
10 61 83 234 396 434 351 335 291 281 318 278 299 295 301 254 174 74 22 6
5 29 40 116 214 225 172 147 130 140 183 208 277 309 339 343 353 266 198 178
Gastrinoma, malignant
0 0 1 1 4 1 8 13 11 13 13 16 10 12 10 6 1 0 0 0
0 0 0 0 2 0 3 5 4 6 7 11 9 12 11 8 2 0 0 0
Adenocarcinoma in situ
0 0 0 10 72 221 351 370 419 562 779 754 730 682 646 555 364 205 62 5
0 0 0 4 39 114 172 163 188 281 449 564 678 714 728 749 738 738 558 148
Carcinosarcoma, NOS
0 0 0 0 1 9 12 17 46 78 153 253 306 387 384 293 266 140 41 9
0 0 0 0 0 4 5 7 20 39 88 189 284 405 433 395 539 504 369 268
Olfactory neurcytoma
0 0 0 1 1 0 0 0 1 0 1 0 0 0 1 1 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 0 0 0
Adenocarcinoma, NOS
3 5 13 99 416 1420 3605 7593 15383 31134 60507 99388 138801 175992 186031 160361 106454 53627 16878 3489
1 2 6 49 225 737 1774 3352 6916 15586 34893 74402 129002 184465 209883 216591 216084 193199 151998 103917
Atypical medullary carcinoma
0 0 0 0 0 0 9 10 10 17 12 29 12 8 5 8 3 3 1 0
0 0 0 0 0 0 4 4 4 8 6 21 11 8 5 10 6 10 9 0
Small cell osteosarcoma
0 0 1 3 0 1 0 0 1 0 0 0 0 0 1 1 0 0 0 0
0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
Intraductal carcinoma, noninfiltrating, NOS
0 0 0 4 19 99 356 1318 3268 4780 4967 4587 4349 4314 3900 3002 1693 673 129 21
0 0 0 1 10 51 175 582 1469 2392 2864 3433 4041 4521 4400 4054 3436 2424 1161 625
Myelodysplastic syndrome, NOS
13 5 6 4 5 11 7 21 33 71 88 128 168 248 402 615 629 427 177 44
6 2 2 1 2 5 3 9 14 35 50 95 156 259 453 830 1276 1538 1594 1310
Epithelioid sarcoma
1 6 15 24 34 19 19 24 22 22 23 20 12 14 14 17 7 4 3 1
0 2 7 11 18 9 9 10 9 11 13 14 11 14 15 22 14 14 27 29
Immunoproliferative disease, NOS
0 0 0 1 0 0 0 0 0 1 0 2 1 1 2 4 3 1 0 0
0 0 0 0 0 0 0 0 0 0 0 1 0 1 2 5 6 3 0 0
Infiltrating duct carcinoma, NOS
0 0 2 10 272 1920 6367 14268 25096 34156 37318 39560 40323 40284 37533 32352 22020 11545 3840 777
0 0 0 4 147 997 3134 6300 11283 17099 21520 29614 37476 42223 42345 43696 44696 41592 34582 23142
Sertoli-Leydig cl tum., p.d. w heterologous elements
0 0 0 0 1 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-small cell carcinoma
0 0 0 0 3 4 19 74 301 698 1199 1788 2188 2475 2962 3083 2107 872 158 31
0 0 0 0 1 2 9 32 135 349 691 1338 2033 2594 3341 4164 4276 3141 1422 923
Granulosa cell-theca cell tumor, mal.
0 0 0 0 0 0 0 0 2 2 1 1 3 1 3 0 1 0 0 0
0 0 0 0 0 0 0 0 0 1 0 0 2 1 3 0 2 0 0 0
Thymoma, type AB, malignant
0 0 1 0 1 5 1 1 5 8 11 3 7 5 11 5 2 2 0 0
0 0 0 0 0 2 0 0 2 4 6 2 6 5 12 6 4 7 0 0
Insular carcinoma
0 0 0 0 0 2 1 3 2 4 2 3 3 2 4 5 3 2 0 0
0 0 0 0 0 1 0 1 0 2 1 2 2 2 4 6 6 7 0 0
Synovial sarcoma, spindle cell
1 2 10 23 14 21 23 20 17 14 16 21 5 4 5 5 1 0 0 0
0 0 4 11 7 10 11 8 7 7 9 15 4 4 5 6 2 0 0 0
Chronic neutrophilic leukemia
0 0 0 0 0 0 0 0 0 1 0 1 1 2 1 2 1 2 0 1
0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 2 7 0 29
Primary cutan. CD30+ T-cell lymphoprolif. disorder
0 3 3 3 6 7 4 8 8 14 22 15 17 13 22 16 10 8 2 1
0 1 1 1 3 3 1 3 3 7 12 11 15 13 24 21 20 28 18 29
Mediastinal large B-cell lymphoma
0 0 0 3 7 12 10 6 10 4 4 1 0 2 1 0 3 0 0 0
0 0 0 1 3 6 4 2 4 2 2 0 0 2 1 0 6 0 0 0
Malignant lymphoma, NOS
31 37 60 77 129 301 470 663 660 672 779 841 1161 1385 1597 1699 1390 990 418 132
16 17 29 38 69 156 231 292 296 336 449 629 1079 1451 1801 2294 2821 3566 3764 3931
Pituitary adenoma, NOS
2 8 19 55 93 111 159 117 185 187 178 185 138 131 112 126 63 34 8 0
1 3 9 27 50 57 78 51 83 93 102 138 128 137 126 170 127 122 72 0
Spindle cell rhabdomyosarcoma
2 1 0 3 0 1 1 0 0 0 1 0 1 0 0 1 0 0 0 0
1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Pseudosarcomatous carcinoma
0 0 0 1 0 3 0 6 5 10 33 33 25 50 55 50 55 24 7 0
0 0 0 0 0 1 0 2 2 5 19 24 23 52 62 67 111 86 63 0
Polycythemia vera
4 2 0 10 6 21 32 33 60 137 141 143 152 174 181 215 159 93 30 15
2 0 0 4 3 10 15 14 26 68 81 107 141 182 204 290 322 335 270 446
Angioimmunoblastic T-cell lymphoma
0 0 1 0 1 1 4 3 12 13 21 28 31 38 40 38 25 16 2 2
0 0 0 0 0 0 1 1 5 6 12 20 28 39 45 51 50 57 18 59
Lentigo maligna
2 1 4 3 20 58 131 253 548 942 1364 1823 2293 2822 3145 3004 2124 1010 317 67
1 0 1 1 10 30 64 111 246 471 786 1364 2131 2957 3548 4057 4311 3638 2854 1995
Astrocytoma, anaplastic
36 54 50 52 97 157 205 187 209 193 181 193 168 220 177 146 67 23 4 0
18 26 24 25 52 81 100 82 93 96 104 144 156 230 199 197 135 82 36 0
Lentigo maligna melanoma
0 0 0 1 12 17 38 95 192 326 463 651 835 1011 1243 1191 932 502 188 38
0 0 0 0 6 8 18 41 86 163 267 487 776 1059 1402 1608 1891 1808 1693 1131
Carcinoma, undifferentiated type, NOS
1 1 8 24 28 43 108 163 303 535 837 1135 1550 1623 1584 1191 740 344 106 17
0 0 3 11 15 22 53 71 136 267 482 849 1440 1701 1787 1608 1502 1239 954 506
Pituitary carcinoma, NOS
0 0 0 0 0 0 0 0 1 1 1 1 0 2 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0
Hodgkin lymphoma, lymphocytic deplet., NOS
0 2 19 16 21 26 42 30 24 29 47 46 53 64 85 69 36 19 13 1
0 0 9 7 11 13 20 13 10 14 27 34 49 67 95 93 73 68 117 29
Mixed islet cell & exocrine adenocarcinoma
0 0 0 0 0 0 0 0 3 2 7 1 2 3 0 3 1 0 0 0
0 0 0 0 0 0 0 0 1 1 4 0 1 3 0 4 2 0 0 0
Malignant placental site trophoblastic tumor
0 0 0 2 5 6 3 2 2 1 1 0 0 0 0 0 0 0 0 0
0 0 0 0 2 3 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Burkitt cell leukemia
12 14 7 6 3 7 4 5 6 9 4 6 7 10 12 7 7 3 0 1
6 6 3 2 1 3 1 2 2 4 2 4 6 10 13 9 14 10 0 29
Scirrhous adenocarcinoma
0 0 0 0 0 9 24 72 130 210 302 350 427 403 409 376 260 141 48 9
0 0 0 0 0 4 11 31 58 105 174 262 396 422 461 507 527 507 432 268
Carcinosarcoma, embryonal type
0 0 0 0 1 0 0 0 1 1 3 3 4 1 4 0 2 0 0 0
0 0 0 0 0 0 0 0 0 0 1 2 3 1 4 0 4 0 0 0
Olfactory neuroblastoma
1 1 5 9 11 10 13 18 25 41 31 37 37 31 12 21 12 5 1 0
0 0 2 4 5 5 6 7 11 20 17 27 34 32 13 28 24 18 9 0
Duct carcinoma, desmoplastic type
0 0 0 0 0 0 0 1 0 0 2 0 1 2 1 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 1 0 0 2 1 1 0 0 0 0
Comedocarcinoma, non-infiltrating
0 0 0 1 4 26 115 362 938 1210 1313 1368 1092 1167 993 784 401 147 29 3
0 0 0 0 2 13 56 159 421 605 757 1024 1014 1223 1120 1058 813 529 261 89
Undifferentiated sarcoma
2 1 3 5 1 0 1 0 0 3 2 3 5 3 5 4 1 0 0 0
1 0 1 2 0 0 0 0 0 1 1 2 4 3 5 5 2 0 0 0
Medulloblastoma, NOS
313 323 175 88 82 72 51 42 21 17 12 6 4 1 1 0 0 1 0 0
163 156 85 43 44 37 25 18 9 8 6 4 3 1 1 0 0 3 0 0
Central osteosarcoma
0 1 1 4 1 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0
0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Comedocarcinoma, NOS
0 0 0 0 8 71 225 452 742 888 871 819 804 723 545 408 235 104 20 7
0 0 0 0 4 36 110 199 333 444 502 613 747 757 614 551 477 374 180 208
Leukemia, NOS
28 10 10 12 15 17 24 31 42 47 75 115 156 255 361 403 425 351 213 69
14 4 4 5 8 8 11 13 18 23 43 86 144 267 407 544 862 1264 1918 2055
Waldenstrom macroglobulinemia
0 1 0 0 1 0 7 14 20 51 98 128 164 208 271 310 236 133 41 4
0 0 0 0 0 0 3 6 8 25 56 95 152 218 305 418 479 479 369 119
Acute myeloid leuk. with multilineage dysplasia
1 1 1 2 5 2 4 3 10 13 23 26 41 47 58 77 62 29 8 0
0 0 0 0 2 1 1 1 4 6 13 19 38 49 65 104 125 104 72 0
Endometrioid carcinoma
0 0 0 5 35 118 370 822 1519 2489 3750 4364 3950 3583 3092 2505 1753 789 240 37
0 0 0 2 18 61 182 362 682 1246 2162 3266 3671 3755 3488 3383 3558 2842 2161 1102
Malignant lymphoma, non-Hodgkin
57 87 104 118 141 200 312 434 519 654 862 1106 1324 1565 1629 1657 1175 651 245 52
29 42 50 58 76 103 153 191 233 327 497 827 1230 1640 1837 2238 2385 2345 2206 1548
NK/T-cell lymphoma, nasal and nasal-type
0 1 1 2 7 7 4 12 11 11 11 13 8 10 13 12 7 2 1 0
0 0 0 0 3 3 1 5 4 5 6 9 7 10 14 16 14 7 9 0
Thymoma, type B1, malignant
0 0 1 1 1 0 7 2 5 8 3 12 7 5 8 10 6 1 0 0
0 0 0 0 0 0 3 0 2 4 1 8 6 5 9 13 12 3 0 0
Angiolipoma, NOS
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0
Synovial sarcoma, epithelioid cell
0 0 0 0 0 1 1 2 0 0 1 0 2 1 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0
Hypereosinophilic syndrome
1 5 1 0 1 1 2 3 8 4 6 6 4 7 8 6 4 2 0 0
0 2 0 0 0 0 0 1 3 2 3 4 3 7 9 8 8 7 0 0
Polygonal cell carcinoma
0 0 0 0 0 0 0 0 0 4 4 2 6 3 5 1 1 0 0 0
0 0 0 0 0 0 0 0 0 2 2 1 5 3 5 1 2 0 0 0
Hodgkin lymphoma, nod. scler., grade 2
0 2 11 41 70 65 80 37 48 26 14 9 5 18 9 11 8 3 0 1
0 0 5 20 37 33 39 16 21 13 8 6 4 18 10 14 16 10 0 29
Superficial spreading melanoma, in situ
2 0 5 37 105 249 340 452 539 512 506 476 419 366 309 257 138 64 22 6
1 0 2 18 56 129 167 199 242 256 291 356 389 383 348 347 280 230 198 178
Adenocarcinoma with squamous metaplasia
0 0 0 1 9 36 83 146 251 309 533 651 686 535 400 253 140 67 9 5
0 0 0 0 4 18 40 64 112 154 307 487 637 560 451 341 284 241 81 148
Superficial spreading melanoma
1 10 50 343 1108 2213 3320 4036 4500 4481 4369 4174 3800 3271 2850 2154 1323 651 187 49
0 4 24 170 600 1150 1634 1782 2023 2243 2519 3124 3531 3428 3215 2909 2685 2345 1684 1459
Carcinoma, anaplastic type, NOS
0 0 1 7 8 12 36 59 132 232 327 470 640 722 681 508 367 202 68 13
0 0 0 3 4 6 17 26 59 116 188 351 594 756 768 686 744 727 612 387
Papillary adenoma, NOS
0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Rhabdomyosarcoma, NOS
52 39 31 34 27 15 14 15 14 23 27 26 30 38 40 34 32 19 6 0
27 18 15 16 14 7 6 6 6 11 15 19 27 39 45 45 64 68 54 0
Vipoma
0 0 0 0 0 0 0 0 1 1 2 2 2 1 2 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 1 1 1 1 2 0 0 0 0 0
Renal cell carcinoma
6 7 17 36 70 164 368 830 1563 2494 3493 4452 5091 5591 5274 4442 2818 1389 437 90
3 3 8 17 37 85 181 366 702 1248 2014 3332 4731 5860 5950 5999 5720 5004 3935 2680
Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
0 0 4 2 4 3 2 3 4 2 2 5 5 4 6 7 4 1 0 0
0 0 1 0 2 1 0 1 1 1 1 3 4 4 6 9 8 3 0 0
Amelanotic melanoma
0 0 2 4 19 24 24 36 43 66 63 60 74 77 85 92 60 42 14 4
0 0 0 1 10 12 11 15 19 33 36 44 68 80 95 124 121 151 126 119
Aortic body tumor, malignant
0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Adult T-cell leukemia/lymphoma (HTLV-1 pos.)
2 0 1 0 6 2 3 15 4 6 10 7 11 8 13 21 18 7 3 0
1 0 0 0 3 1 1 6 1 3 5 5 10 8 14 28 36 25 27 0
Trophoblastic tumor, epithelioid
0 0 0 0 1 0 1 6 2 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0
Malignant myoepithelioma
0 1 3 0 1 0 1 3 8 3 6 1 7 7 11 4 6 3 0 0
0 0 1 0 0 0 0 1 3 1 3 0 6 7 12 5 12 10 0 0
Olfactory neuroepithelioma
0 0 0 0 0 1 1 0 1 2 1 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Papillary adenocarcinoma, NOS
0 5 53 236 609 1088 1366 1554 1741 2150 2508 3010 3334 3462 3255 2582 1840 932 278 61
0 2 25 117 330 565 672 686 782 1076 1446 2253 3098 3628 3672 3487 3734 3357 2503 1816
Linitis plastica
0 0 0 0 5 6 20 38 49 97 119 162 199 216 235 236 166 84 27 7
0 0 0 0 2 3 9 16 22 48 68 121 184 226 265 318 336 302 243 208
Retinoblastoma, NOS
629 31 3 2 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0
328 15 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Desmoplastic medulloblastoma
29 12 9 8 11 5 8 7 4 5 3 0 1 1 0 0 0 0 0 0
15 5 4 3 5 2 3 3 1 2 1 0 0 1 0 0 0 0 0 0
Desmoplastic small round cell tumor
0 1 9 4 7 6 9 6 2 0 1 0 0 1 0 2 0 0 0 0
0 0 4 1 3 3 4 2 0 0 0 0 0 1 0 2 0 0 0 0
Ceruminous adenocarcinoma
0 0 0 0 0 1 0 1 0 1 1 2 1 0 5 2 1 0 2 0
0 0 0 0 0 0 0 0 0 0 0 1 0 0 5 2 2 0 18 0
Endometrioid adenofibroma, malignant
0 0 0 0 0 1 2 2 3 1 3 6 6 2 3 9 5 1 0 0
0 0 0 0 0 0 0 0 1 0 1 4 5 2 3 12 10 3 0 0
Acute leukemia, NOS
139 61 45 46 47 51 56 81 79 98 127 185 268 351 530 530 503 372 136 64
72 29 22 22 25 26 27 35 35 49 73 138 249 367 597 715 1021 1340 1224 1906
Heavy chain disease, NOS
0 0 0 0 0 0 0 2 1 0 2 1 1 1 3 2 3 0 0 0
0 0 0 0 0 0 0 0 0 0 1 0 0 1 3 2 6 0 0 0
Secretory carcinoma of breast
0 0 2 3 1 2 5 1 7 5 9 10 3 4 5 5 6 1 2 1
0 0 0 1 0 1 2 0 3 2 5 7 2 4 5 6 12 3 18 29
Basal cell carcinoma, NOS
0 0 0 0 2 2 6 11 21 21 41 56 72 92 121 125 106 95 37 9
0 0 0 0 1 1 2 4 9 10 23 41 66 96 136 168 215 342 333 268
Hemangioblastoma
1 0 2 2 9 13 9 12 18 13 9 22 7 6 6 1 1 3 0 1
0 0 0 0 4 6 4 5 8 6 5 16 6 6 6 1 2 10 0 29
Acute myeloid leukemia, t(8;21)(q22;q22)
3 4 2 3 5 8 4 2 3 11 7 4 10 11 7 6 10 1 0 0
1 1 0 1 2 4 1 0 1 5 4 2 9 11 7 8 20 3 0 0
Thymoma, type B2, malignant
0 0 0 0 0 1 4 1 3 5 7 4 7 2 1 1 3 0 0 0
0 0 0 0 0 0 1 0 1 2 4 2 6 2 1 1 6 0 0 0
Synovial sarcoma, biphasic
0 6 14 23 18 16 21 13 15 13 6 9 4 6 3 1 0 1 0 0
0 2 6 11 9 8 10 5 6 6 3 6 3 6 3 1 0 3 0 0
Carcinoma with osteoclast-like giant cells
0 0 0 0 0 0 0 1 0 0 1 0 0 0 1 1 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 0 0 0
Transitional meningioma
2 0 1 1 2 4 9 8 17 28 20 34 25 26 17 15 10 4 2 0
1 0 0 0 1 2 4 3 7 14 11 25 23 27 19 20 20 14 18 0
Adenocarcinoma w cartilag. & oss. metaplas.
0 0 0 0 0 0 0 0 2 2 6 0 3 2 6 1 2 1 0 1
0 0 0 0 0 0 0 0 0 1 3 0 2 2 6 1 4 3 0 29
Acute basophilic leukemia
0 0 0 0 0 0 0 0 0 1 1 1 1 0 2 1 1 0 1 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 9 0
Pleomorphic carcinoma
0 0 0 0 2 2 4 13 19 22 37 66 72 73 81 67 47 23 5 1
0 0 0 0 1 1 1 5 8 11 21 49 66 76 91 90 95 82 45 29
Basophil adenoma
0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Pleomorphic rhabdomyosarcoma, adult type
2 3 1 9 5 2 5 6 8 6 10 9 12 13 14 13 15 6 4 1
1 1 0 4 2 1 2 2 3 3 5 6 11 13 15 17 30 21 36 29
Acral lentiginous melanoma, malig.
0 0 2 5 13 17 24 42 57 59 70 79 94 101 120 108 85 43 16 5
0 0 0 2 7 8 11 18 25 29 40 59 87 105 135 145 172 154 144 148
Clear cell adenocarcinofibroma
0 0 0 0 0 0 0 0 0 1 2 0 1 3 1 2 0 1 1 0
0 0 0 0 0 0 0 0 0 0 1 0 0 3 1 2 0 3 9 0
Hodgkin lymphoma, lymphocyt. deplet., reticular
0 0 0 2 2 2 4 3 2 3 1 9 10 9 6 9 10 3 1 0
0 0 0 0 1 1 1 1 0 1 0 6 9 9 6 12 20 10 9 0
Somatostatinoma, malignant
0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 0 0
Adenocarcinoma in situ in villous adenoma
0 0 0 0 4 6 12 32 73 143 296 435 589 724 780 792 474 278 69 15
0 0 0 0 2 3 5 14 32 71 170 325 547 758 880 1069 962 1001 621 446
Carotid body tumor, malignant
0 0 0 0 1 0 2 2 2 0 1 1 1 0 0 0 0 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0
Basophil carcinoma
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Adenocarcinoma in villous adenoma
0 0 0 1 6 18 57 136 237 486 924 1418 1972 2581 2746 2737 2125 1175 375 61
0 0 0 0 3 9 28 60 106 243 532 1061 1832 2705 3098 3696 4313 4233 3377 1816
Superficial spreading adenocarcinoma
0 0 0 0 0 2 2 3 5 14 13 19 22 30 29 16 18 7 2 1
0 0 0 0 0 1 0 1 2 7 7 14 20 31 32 21 36 25 18 29
Papillary trans. cell carcinoma, non-invasive
0 0 0 0 3 3 17 21 49 72 120 217 257 393 485 473 321 114 32 7
0 0 0 0 1 1 8 9 22 36 69 162 238 411 547 638 651 410 288 208
Noninfiltrating intraductal papillary adenocarcinoma
0 0 0 0 1 11 46 97 224 315 323 299 358 407 453 358 236 91 24 5
0 0 0 0 0 5 22 42 100 157 186 223 332 426 511 483 479 327 216 148
Papillary trans. cell carcinoma
0 4 8 69 163 312 551 1019 1869 3237 5436 8509 11584 15025 16782 15822 11496 6128 2126 474
0 1 3 34 88 162 271 449 840 1620 3134 6369 10766 15748 18933 21369 23334 22077 19146 14117
Hepatoblastoma
275 17 7 4 0 1 1 0 0 0 1 0 1 2 3 1 2 0 1 0
143 8 3 1 0 0 0 0 0 0 0 0 0 2 3 1 4 0 9 0
Retinoblastoma, differentiated
41 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
21 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Medullomyoblastoma
0 3 0 0 0 0 0 2 0 0 1 0 0 0 0 0 0 0 0 0
0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intraductal papillary adenocarcinoma with invasion
0 0 0 0 0 5 11 29 43 81 82 102 134 134 163 124 138 60 16 2
0 0 0 0 0 2 5 12 19 40 47 76 124 140 183 167 280 216 144 59
Multifocal superficial basal cell carcinoma
0 0 0 0 0 0 0 0 0 0 0 1 1 5 1 3 2 2 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 5 1 4 4 7 0 0
Endometrioid adenocarcinoma, secretory variant
0 0 0 0 1 2 0 4 4 4 5 4 5 4 6 2 1 0 0 0
0 0 0 0 0 1 0 1 1 2 2 2 4 4 6 2 2 0 0 0
Granular cell tumor, NOS
0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Acute myeloid leukemia, 11q23 abnormalities
1 0 0 1 1 0 2 1 1 4 1 1 2 4 5 0 5 2 0 0
0 0 0 0 0 0 0 0 0 2 0 0 1 4 5 0 10 7 0 0
Malignant histiocytosis
32 10 18 12 11 12 5 14 8 12 15 18 26 28 23 21 6 12 4 0
16 4 8 5 5 6 2 6 3 6 8 13 24 29 25 28 12 43 36 0
Clear cell sarcoma,NOS (except of kidney M-8964/3)
3 1 5 13 13 12 7 7 14 12 12 10 7 2 7 4 4 1 0 0
1 0 2 6 7 6 3 3 6 6 6 7 6 2 7 5 8 3 0 0
Thymoma, type B3, malignant
0 0 0 0 0 3 5 4 7 9 10 11 9 14 9 6 3 2 1 0
0 0 0 0 0 1 2 1 3 4 5 8 8 14 10 8 6 7 9 0
Granular cell tumor, malignant
1 0 1 1 3 3 1 2 5 7 5 5 8 2 5 2 3 1 0 1
0 0 0 0 1 1 0 0 2 3 2 3 7 2 5 2 6 3 0 29
Subcutaneous panniculitis-like T-cell lymphoma
0 0 0 4 0 0 1 3 1 0 3 5 2 4 2 2 3 0 0 0
0 0 0 1 0 0 0 1 0 0 1 3 1 4 2 2 6 0 0 0
Ac. myelomonocytic leuk. w abn. mar. eosinophils
1 0 4 2 1 6 4 3 5 5 3 10 4 5 5 5 1 1 1 0
0 0 1 0 0 3 1 1 2 2 1 7 3 5 5 6 2 3 9 0
Clear cell meningioma
0 1 0 1 2 1 0 1 4 1 0 1 2 1 2 1 1 1 0 0
0 0 0 0 1 0 0 0 1 0 0 0 1 1 2 1 2 3 0 0
Adenocarcinoma with spindle cell mataplasia
0 0 0 0 0 0 2 3 0 2 4 4 4 6 3 5 5 0 0 0
0 0 0 0 0 0 0 1 0 1 2 2 3 6 3 6 10 0 0 0
Lipoma, NOS
2 2 3 2 2 1 0 1 1 1 0 0 2 1 2 2 0 0 0 0
1 0 1 0 1 0 0 0 0 0 0 0 1 1 2 2 0 0 0 0
Signet ring cell carcinoma
0 0 4 11 54 106 198 334 523 667 869 1103 1245 1513 1566 1435 1115 628 209 49
0 0 1 5 29 55 97 147 235 333 501 825 1157 1585 1766 1938 2263 2262 1882 1459
Desmoplastic melanoma, malignant
0 0 1 1 3 5 24 29 41 47 68 60 81 93 107 99 110 53 22 4
0 0 0 0 1 2 11 12 18 23 39 44 75 97 120 133 223 190 198 119
Mixed type rhabdomyosarcoma
4 5 3 2 0 1 2 0 1 2 0 1 0 0 0 2 0 1 0 0
2 2 1 0 0 0 0 0 0 1 0 0 0 0 0 2 0 3 0 0
Hairy cell leukemia
0 0 0 1 7 19 65 132 203 248 254 250 223 240 209 171 120 62 16 3
0 0 0 0 3 9 31 58 91 124 146 187 207 251 235 230 243 223 144 89
Papillary meningioma
0 3 0 0 1 1 0 1 1 2 0 2 2 3 2 0 0 0 0 0
0 1 0 0 0 0 0 0 0 1 0 1 1 3 2 0 0 0 0 0
Carcinoma in situ, NOS
0 1 11 1247 7771 13010 10978 6899 4434 2844 2117 1856 1759 1594 1314 884 576 284 80 16
0 0 5 620 4214 6761 5404 3046 1993 1423 1220 1389 1634 1670 1482 1193 1169 1023 720 476
Lipid-rich carcinoma
0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 0 0
Paraganglioma, NOS
0 0 0 0 0 0 1 1 0 4 1 1 1 2 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 2 0 0 0 2 0 0 0 0 0 0
Extra-adrenal paraganglioma, malignant
0 0 1 1 2 2 3 5 3 3 3 4 5 1 2 0 0 0 0 0
0 0 0 0 1 1 1 2 1 1 1 2 4 1 2 0 0 0 0 0
Carcinoma, NOS
10 6 16 89 269 554 978 1655 2761 4944 7823 11536 16294 21798 26409 28894 28114 20694 10153 3246
5 2 7 44 145 287 481 730 1241 2475 4511 8635 15143 22847 29795 39025 57066 74553 91435 96679
Liposarcoma, NOS
0 1 0 8 9 20 49 50 60 105 109 161 153 140 163 141 116 57 20 3
0 0 0 3 4 10 24 22 26 52 62 120 142 146 183 190 235 205 180 89
Adenocarcinoma, intestinal type
0 0 0 0 1 5 7 15 38 77 107 174 254 349 482 537 470 285 127 21
0 0 0 0 0 2 3 6 17 38 61 130 236 365 543 725 954 1026 1143 625
Odontogenic tumor, malignant
0 2 0 0 3 3 0 3 2 3 3 3 8 2 1 5 3 1 0 0
0 0 0 0 1 1 0 1 0 1 1 2 7 2 1 6 6 3 0 0
Villous adenocarcinoma
0 0 0 0 2 3 6 11 16 26 36 56 110 115 124 96 95 62 14 0
0 0 0 0 1 1 2 4 7 13 20 41 102 120 139 129 192 223 126 0
Paraganglioma, malignant
0 1 1 1 3 10 8 13 14 12 10 11 6 14 6 6 6 2 1 0
0 0 0 0 1 5 3 5 6 6 5 8 5 14 6 8 12 7 9 0
Transitional cell carcinoma, micropapillary
0 0 0 0 0 0 0 0 1 0 3 2 3 6 7 1 8 3 0 1
0 0 0 0 0 0 0 0 0 0 1 1 2 6 7 1 16 10 0 29
Pancreatoblastoma
1 4 2 0 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0
0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Retinoblastoma, undifferentiated
40 3 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
20 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Primitive neuroectodermal tumor
140 71 52 40 41 30 26 21 30 17 7 12 7 6 2 5 6 0 0 0
73 34 25 19 22 15 12 9 13 8 4 8 6 6 2 6 12 0 0 0
Noninfiltrating intracystic carcinoma
0 0 0 0 0 0 1 4 13 26 26 30 43 62 75 58 55 35 14 1
0 0 0 0 0 0 0 1 5 13 14 22 39 64 84 78 111 126 126 29
Infiltrating basal cell carcinoma, NOS
0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 1 0 1 1 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 3 9 0
Endometrioid adenocarcinoma, ciliated cell variant
0 0 0 0 0 0 0 2 0 1 1 1 3 1 2 4 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 5 2 0 0 0
Immunoproliferative small intestinal disease
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0
Intracystic carcinoma, NOS
0 0 0 0 2 4 7 13 25 28 26 33 52 65 72 76 72 36 17 5
0 0 0 0 1 2 3 5 11 14 14 24 48 68 81 102 146 129 153 148
Oligodendroblastoma
0 0 1 1 1 2 2 4 6 6 2 5 2 1 2 1 0 0 0 0
0 0 0 0 0 1 0 1 2 3 1 3 1 1 2 1 0 0 0 0
Adrenal cortical carcinoma
27 10 8 16 13 27 35 58 63 66 86 78 100 82 64 30 23 8 2 1
14 4 3 7 7 14 17 25 28 33 49 58 92 85 72 40 46 28 18 29
Hemangiopericytoma, benign
0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Hemangiopericytoma, NOS
0 0 0 0 0 1 0 1 2 2 0 2 2 1 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 1 0 1 1 1 0 0 0 0 0 0
Thymic carcinoma, NOS
0 0 0 0 0 1 2 4 9 14 6 14 11 9 14 8 2 2 0 0
0 0 0 0 0 0 0 1 4 7 3 10 10 9 15 10 4 7 0 0
Alveolar soft part sarcoma
2 6 12 15 18 23 7 9 3 3 1 4 2 0 1 1 0 0 0 0
1 2 5 7 9 11 3 3 1 1 0 2 1 0 1 1 0 0 0 0
Atypical meningioma
0 0 0 1 2 1 5 10 8 17 16 20 22 18 16 16 14 8 1 0
0 0 0 0 1 0 2 4 3 8 9 14 20 18 18 21 28 28 9 0
Adenocarcinoma with apocrine metaplasia
0 0 0 0 0 0 1 0 4 6 9 3 3 5 5 8 1 1 1 0
0 0 0 0 0 0 0 0 1 3 5 2 2 5 5 10 2 3 9 0
Cutaneous T-cell lymphoma, NOS
0 3 2 5 7 16 37 50 59 83 120 104 107 120 137 130 71 35 16 4
0 1 0 2 3 8 18 22 26 41 69 77 99 125 154 175 144 126 144 119
Acute myeloid leukemia, minimal differentiation
5 3 6 11 6 5 9 7 14 12 25 22 25 46 49 41 34 28 6 0
2 1 2 5 3 2 4 3 6 6 14 16 23 48 55 55 69 100 54 0
Hemangiopericytoma, malignant
8 6 5 6 13 8 23 25 34 23 44 29 34 23 28 31 16 8 0 1
4 2 2 2 7 4 11 11 15 11 25 21 31 24 31 41 32 28 0 29
Mucosal lentiginous melanoma
0 0 0 0 0 1 0 0 0 0 4 1 0 0 0 3 0 0 0 0
0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 4 0 0 0 0
Meningeal sarcomatosis
0 0 0 0 0 0 0 0 0 2 2 0 1 1 0 0 2 0 0 0
0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 4 0 0 0
Adenosquamous carcinoma
1 0 2 1 18 103 216 350 499 621 964 1388 1627 1687 1637 1290 691 302 79 10
0 0 0 0 9 53 106 154 224 310 555 1039 1512 1768 1846 1742 1402 1088 711 297
Glycogen-rich carcinoma
0 0 0 0 0 0 1 0 0 1 0 1 1 2 0 3 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 4 0 0 0 0
Epithelioma, malignant
0 0 0 0 0 0 0 1 0 2 1 1 4 2 2 1 1 1 0 0
0 0 0 0 0 0 0 0 0 1 0 0 3 2 2 1 2 3 0 0
Adenocarcinoma in situ in tubulovillous adenoma
0 0 0 1 2 12 35 56 121 201 446 591 749 904 986 922 604 312 95 15
0 0 0 0 1 6 17 24 54 100 257 442 696 947 1112 1245 1226 1124 855 446
Liposarcoma, well differentiated
0 0 0 1 9 14 19 49 73 70 115 135 121 130 117 121 69 22 9 1
0 0 0 0 4 7 9 21 32 35 66 101 112 136 132 163 140 79 81 29
Ameloblastoma, malignant
0 1 1 5 5 5 7 8 4 7 8 5 8 12 4 7 3 3 0 0
0 0 0 2 2 2 3 3 1 3 4 3 7 12 4 9 6 10 0 0
Adenocarcinoma in tubulovillous adenoma
0 0 1 0 11 30 62 155 328 601 1173 1567 1938 2567 2803 2860 2034 1031 320 66
0 0 0 0 5 15 30 68 147 300 676 1173 1801 2690 3162 3862 4128 3714 2881 1965
Carcinoma, diffuse type
0 0 0 1 4 9 22 29 47 73 94 109 132 163 195 199 127 90 33 6
0 0 0 0 2 4 10 12 21 36 54 81 122 170 220 268 257 324 297 178
Melanoma in situ
2 6 34 134 375 713 1142 1627 2107 2377 2519 2605 2349 2266 2242 1947 1248 566 188 37
1 2 16 66 203 370 562 718 947 1189 1452 1950 2183 2375 2529 2629 2533 2039 1693 1102
Malignant melanoma, NOS
30 36 105 460 1157 2098 2788 3506 4166 4644 4855 4963 4810 4640 4392 3785 2803 1579 577 194
15 17 51 228 627 1090 1372 1548 1873 2324 2799 3715 4470 4863 4955 5112 5689 5688 5196 5778
Large cell medulloblastoma
4 1 1 1 1 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bronchiolo-alveolar adenocarcinoma
0 0 0 2 2 6 31 77 205 413 847 1292 1830 2184 2217 1805 949 317 77 15
0 0 0 0 1 3 15 34 92 206 488 967 1700 2289 2501 2437 1926 1142 693 446
Retinoblastoma, diffuse
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pulmonary blastoma
3 0 1 1 3 2 0 2 0 1 0 1 3 4 2 2 1 0 0 0
1 0 0 0 1 1 0 0 0 0 0 0 2 4 2 2 2 0 0 0
Basal cell carcinoma, fibroepithelial
0 0 0 0 0 0 0 0 0 1 1 2 3 2 1 2 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 1 2 2 1 2 0 0 0 0
Adenocarcinoma, endocervical type
0 0 0 0 2 12 21 21 17 24 11 6 7 1 2 6 2 0 0 0
0 0 0 0 1 6 10 9 7 12 6 4 6 1 2 8 4 0 0 0
Queyrat erythroplasia
0 0 0 0 2 4 5 7 4 5 11 9 16 16 8 14 9 3 1 0
0 0 0 0 1 2 2 3 1 2 6 6 14 16 9 18 18 10 9 0
Neuroblastoma, NOS
1495 140 42 29 15 18 13 14 7 6 5 8 7 6 5 3 0 5 1 0
780 68 20 14 8 9 6 6 3 3 2 5 6 6 5 4 0 18 9 0
Sebaceous adenocarcinoma
0 0 0 0 1 2 4 12 12 45 38 64 66 101 119 137 128 73 35 13
0 0 0 0 0 1 1 5 5 22 21 47 61 105 134 185 259 262 315 387
Acute myeloid leukemia without maturation
6 5 10 7 17 14 13 13 23 26 23 47 36 41 66 69 40 29 3 0
3 2 4 3 9 7 6 5 10 13 13 35 33 42 74 93 81 104 27 0
Adenocarcinoma with neuroendocrine differen.
0 0 0 0 0 1 0 1 7 6 15 21 15 17 14 18 13 5 4 0
0 0 0 0 0 0 0 0 3 3 8 15 13 17 15 24 26 18 36 0
Cyst-associated renal cell carcinoma
0 0 0 0 0 2 8 15 21 35 29 23 21 27 32 14 12 7 2 0
0 0 0 0 0 1 3 6 9 17 16 17 19 28 36 18 24 25 18 0
Phyllodes tumor, malignant
0 0 5 14 17 28 38 87 113 143 126 121 87 70 47 39 36 11 8 2
0 0 2 6 9 14 18 38 50 71 72 90 80 73 53 52 73 39 72 59
Myeloid leukemia, NOS
16 8 5 10 20 16 46 27 40 52 65 82 150 203 280 290 299 190 83 23
8 3 2 4 10 8 22 11 17 26 37 61 139 212 315 391 606 684 747 685
Thecoma, malignant
0 0 0 1 2 0 1 2 0 3 2 1 5 3 5 1 1 1 0 0
0 0 0 0 1 0 0 0 0 1 1 0 4 3 5 1 2 3 0 0
Warthin tumor, malignant
0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Myxoid liposarcoma
2 3 7 20 22 72 76 117 125 104 87 99 100 101 84 72 59 31 9 2
1 1 3 9 11 37 37 51 56 52 50 74 92 105 94 97 119 111 81 59
Large cell carcinoma, NOS
0 0 0 0 12 24 80 307 799 1475 2509 3653 4606 5150 4776 3652 1969 751 164 25
0 0 0 0 6 12 39 135 359 738 1446 2734 4280 5397 5388 4932 3996 2705 1476 744
Nodular melanoma
1 8 13 55 187 285 423 515 652 703 771 835 810 859 852 787 655 412 213 49
0 3 6 27 101 148 208 227 293 351 444 625 752 900 961 1062 1329 1484 1918 1459
Pleuropulmonary blastoma
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Alveolar adenocarcinoma
0 0 0 0 0 1 2 2 8 15 17 46 60 80 69 42 34 14 1 1
0 0 0 0 0 0 0 0 3 7 9 34 55 83 77 56 69 50 9 29
Transitional cell carcinoma in situ
0 0 0 1 2 1 5 4 8 22 43 75 100 156 205 185 105 44 14 6
0 0 0 0 1 0 2 1 3 11 24 56 92 163 231 249 213 158 126 178
Basosquamous carcinoma
0 0 0 0 0 1 1 1 6 8 9 17 12 14 25 17 26 14 8 0
0 0 0 0 0 0 0 0 2 4 5 12 11 14 28 22 52 50 72 0
Acute biphenotypic leukemia
4 4 1 3 0 0 2 1 0 1 3 4 3 4 3 4 4 0 1 0
2 1 0 1 0 0 0 0 0 0 1 2 2 4 3 5 8 0 9 0
Transitional cell carcinoma, NOS
0 1 4 14 37 70 144 297 618 1264 2325 3862 5920 7636 8585 8666 6918 3951 1434 315
0 0 1 6 20 36 70 131 277 632 1340 2891 5502 8003 9685 11704 14042 14234 12914 9382
Bowen disease
0 0 0 23 89 194 258 311 288 269 246 242 203 200 171 138 57 40 9 1
0 0 0 11 48 100 127 137 129 134 141 181 188 209 192 186 115 144 81 29
Nephroblastoma, NOS
1039 319 50 21 18 12 8 3 10 3 6 3 5 3 3 4 0 0 0 0
542 155 24 10 9 6 3 1 4 1 3 2 4 3 3 5 0 0 0 0
Medulloepithelioma, NOS
10 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Composite Hodgkin and non-Hodgkin lymphoma
0 0 0 0 0 0 2 2 0 1 1 1 2 2 5 3 4 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0 1 2 5 4 8 3 0 0
Spindle epithelial tumor with thymus-like element
0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Neuroma, NOS
0 0 1 0 1 1 1 3 4 2 11 8 3 1 2 3 1 1 0 0
0 0 0 0 0 0 0 1 1 1 6 5 2 1 2 4 2 3 0 0
Mast cell sarcoma
0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Acute myeloid leukemia with maturation
8 10 19 10 14 15 12 23 30 40 43 49 51 68 79 77 76 39 16 1
4 4 9 4 7 7 5 10 13 20 24 36 47 71 89 104 154 140 144 29
Metaplastic carcinoma, NOS
0 0 0 0 1 1 5 17 21 42 34 57 44 39 20 45 26 13 9 3
0 0 0 0 0 0 2 7 9 21 19 42 40 40 22 60 52 46 81 89
Renal cell carcinoma, chromophobe type
0 0 0 1 4 9 24 25 73 78 82 99 80 72 83 100 51 17 3 0
0 0 0 0 2 4 11 11 32 39 47 74 74 75 93 135 103 61 27 0
Acute myeloid leukemia
317 187 235 331 394 442 473 581 614 790 984 1256 1587 2017 2450 2441 1963 1076 417 83
165 90 115 164 213 229 232 256 276 395 567 940 1474 2114 2764 3296 3984 3876 3755 2472
Neoplasm, benign
3 2 5 4 8 9 8 7 4 16 10 12 8 11 11 14 13 12 2 0
1 0 2 1 4 4 3 3 1 8 5 8 7 11 12 18 26 43 18 0
Epithelial-myoepithelial carcinoma
0 0 1 0 0 1 3 6 3 10 21 12 10 13 12 18 10 6 3 1
0 0 0 0 0 0 1 2 1 5 12 8 9 13 13 24 20 21 27 29
Mucinous adenocarcinoma
0 0 5 34 94 194 420 801 1395 2175 2914 3804 4912 6366 7240 7224 5503 3187 1089 241
0 0 2 16 50 100 206 353 627 1088 1680 2847 4565 6672 8168 9757 11170 11481 9807 7178
Hodgkin lymph., nodular lymphocyte predom.
2 11 14 37 43 71 55 55 48 46 40 33 33 11 14 9 8 1 0 0
1 5 6 18 23 36 27 24 21 23 23 24 30 11 15 12 16 3 0 0
Neoplasm, uncertain whether benign or malignant
0 2 3 2 8 6 6 11 9 8 13 10 13 11 16 19 30 27 14 2
0 0 1 0 4 3 2 4 4 4 7 7 12 11 18 25 60 97 126 59
Large cell neuroendocrine carcinoma
0 0 0 0 1 0 1 8 15 22 28 70 57 79 73 85 42 22 1 0
0 0 0 0 0 0 0 3 6 11 16 52 52 82 82 114 85 79 9 0
Round cell liposarcoma
0 0 0 1 1 3 12 15 10 22 11 11 9 6 5 9 3 2 2 0
0 0 0 0 0 1 5 6 4 11 6 8 8 6 5 12 6 7 18 0
Myeloid sarcoma
9 1 3 4 3 8 4 6 7 13 16 14 21 20 33 27 12 7 4 0
4 0 1 1 1 4 1 2 3 6 9 10 19 20 37 36 24 25 36 0
Basal cell adenocarcinoma
0 0 0 1 0 1 2 2 1 6 6 12 10 14 17 9 3 2 0 1
0 0 0 0 0 0 0 0 0 3 3 8 9 14 19 12 6 7 0 29
Neoplasm, malignant
67 28 37 59 133 192 265 388 598 985 1567 2387 3678 4985 7201 9132 10851 9643 5762 2070
34 13 18 29 72 99 130 171 268 493 903 1786 3418 5225 8124 12334 22025 34740 51891 61653
Myxosarcoma
0 1 0 0 2 3 4 5 7 5 11 12 9 10 6 10 5 4 1 0
0 0 0 0 1 1 1 2 3 2 6 8 8 10 6 13 10 14 9 0
Balloon cell melanoma
0 0 0 0 0 3 2 1 4 2 2 3 1 1 2 2 1 3 0 0
0 0 0 0 0 1 0 0 1 1 1 2 0 1 2 2 2 10 0 0
Bronchiolo-alveolar carcinoma, non-mucinous
0 0 0 0 0 0 1 1 4 10 11 29 23 29 37 36 29 9 1 0
0 0 0 0 0 0 0 0 1 5 6 21 21 30 41 48 58 32 9 0
Intraductal micropapillary carcinoma
0 0 0 0 1 2 8 34 96 149 148 122 104 102 78 76 35 14 2 0
0 0 0 0 0 1 3 15 43 74 85 91 96 106 88 102 71 50 18 0
Ewing sarcoma
36 132 272 309 151 80 47 32 23 19 15 6 5 4 5 2 1 0 0 1
18 64 133 153 81 41 23 14 10 9 8 4 4 4 5 2 2 0 0 29
Metatypical carcinoma
0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0
Steroid cell tumor, malignant
0 0 0 0 0 0 0 3 1 0 1 2 1 1 0 0 1 0 0 0
0 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 2 0 0 0
Teratoid medulloepithelioma
1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Struma ovarii, malignant
0 0 0 0 1 1 3 1 3 4 1 1 0 0 1 1 0 1 0 0
0 0 0 0 0 0 1 0 1 2 0 0 0 0 1 1 0 3 0 0
Schneiderian carcinoma
0 0 0 0 0 0 0 1 2 1 3 3 2 5 2 3 1 1 0 0
0 0 0 0 0 0 0 0 0 0 1 2 1 5 2 4 2 3 0 0
Langerhans cell histiocytosis, disseminated
57 6 3 1 4 2 2 1 2 2 2 0 1 2 3 2 0 1 0 0
29 2 1 0 2 1 0 0 0 1 1 0 0 2 3 2 0 3 0 0
Lymphoepithelial carcinoma
0 1 18 37 29 34 46 57 77 101 99 95 81 89 58 39 24 14 4 1
0 0 8 18 15 17 22 25 34 50 57 71 75 93 65 52 48 50 36 29
Oligodendroglioma, NOS
33 41 61 87 124 206 256 335 280 237 201 162 125 103 66 38 29 8 2 1
17 19 29 43 67 107 126 147 125 118 115 121 116 107 74 51 58 28 18 29
Carcinoma showing thymus-like element
0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Perineurioma, NOS
0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Malignant mastocytosis
1 1 0 0 5 2 6 13 12 13 15 16 21 8 10 11 10 0 0 0
0 0 0 0 2 1 2 5 5 6 8 11 19 8 11 14 20 0 0 0
Hepatoid adenocarcinoma
0 0 0 1 0 0 0 0 0 2 2 0 0 2 4 2 0 1 2 0
0 0 0 0 0 0 0 0 0 1 1 0 0 2 4 2 0 3 18 0
Chronic myelogenous leukemia, BCR/ABL positive
0 0 2 8 13 12 16 19 32 36 31 24 26 27 24 21 13 6 0 0
0 0 0 3 7 6 7 8 14 18 17 17 24 28 27 28 26 21 0 0
Perineurioma, malignant
0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Renal cell carcinoma, sarcomatoid
0 0 0 0 0 1 2 6 19 27 32 40 47 35 43 36 17 3 3 1
0 0 0 0 0 0 0 2 8 13 18 29 43 36 48 48 34 10 27 29
Trabecular adenocarcinoma
0 0 0 1 2 2 4 5 0 7 12 21 16 23 21 40 15 12 4 2
0 0 0 0 1 1 1 2 0 3 6 15 14 24 23 54 30 43 36 59
Mucin-producing adenocarcinoma
1 0 3 11 27 91 195 334 670 1046 1647 2345 3056 3715 4037 3769 2733 1533 473 101
0 0 1 5 14 47 95 147 301 523 949 1755 2840 3893 4554 5090 5547 5522 4259 3008
Tumor cells, benign
0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 1 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9 0
Kaposi sarcoma
0 1 0 10 217 1368 3054 3426 2401 1374 650 353 218 169 222 258 247 185 85 23
0 0 0 4 117 710 1503 1512 1079 687 374 264 202 177 250 348 501 666 765 685
Pleomorphic liposarcoma
0 0 0 2 4 1 10 8 22 25 35 35 41 50 68 53 36 24 7 1
0 0 0 0 2 0 4 3 9 12 20 26 38 52 76 71 73 86 63 29
Large cell carcinoma with rhabdoid phenotype
0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 3 0 0
Acinar cell carcinoma
0 3 26 45 40 73 71 92 216 406 1007 1659 1904 2265 1911 1289 665 277 80 8
0 1 12 22 21 37 34 40 97 203 580 1241 1769 2374 2156 1740 1349 997 720 238
Acute panmyelosis with myelofibrosis
0 0 0 0 1 3 2 4 2 4 4 5 11 21 13 14 8 4 0 1
0 0 0 0 0 1 0 1 0 2 2 3 10 22 14 18 16 14 0 29
Adamantinoma of long bones
1 1 4 3 4 3 6 0 5 1 3 1 2 1 0 0 0 0 0 0
0 0 1 1 2 1 2 0 2 0 1 0 1 1 0 0 0 0 0 0
Malignant melanoma, regressing
0 0 1 0 7 15 26 27 33 39 49 42 40 47 40 36 19 11 2 2
0 0 0 0 3 7 12 11 14 19 28 31 37 49 45 48 38 39 18 59
Tumor cells, malignant
2 0 1 4 6 12 15 33 54 100 161 226 372 535 607 552 466 290 118 39
1 0 0 1 3 6 7 14 24 50 92 169 345 560 684 745 945 1044 1062 1161
Bronchiolo-alveolar carcinoma, mucinous
0 0 0 0 1 1 0 3 2 17 16 17 38 42 54 42 23 9 0 2
0 0 0 0 0 0 0 1 0 8 9 12 35 44 60 56 46 32 0 59
Glomangiosarcoma
0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0
Trans. cell carcinoma, spindle cell
0 0 0 0 0 1 1 0 2 4 7 9 14 12 13 28 29 15 6 0
0 0 0 0 0 0 0 0 0 2 4 6 13 12 14 37 58 54 54 0
Neuroepithelioma, NOS
16 3 5 7 4 6 4 7 3 5 5 2 1 9 3 2 2 0 0 0
8 1 2 3 2 3 1 3 1 2 2 1 0 9 3 2 4 0 0 0
Carcinoid tumor, malignant
1 1 39 97 162 289 451 616 889 1233 1842 1958 1986 2128 2060 1654 1045 489 111 17
0 0 19 48 87 150 222 272 399 617 1062 1465 1845 2230 2324 2233 2121 1761 999 506
Basaloid squamous cell carcinoma
0 0 0 0 0 0 4 7 28 49 97 88 67 80 77 55 39 16 5 0
0 0 0 0 0 0 1 3 12 24 55 65 62 83 86 74 79 57 45 0
Eccrine adenocarcinoma
0 0 0 0 2 1 1 1 3 3 3 4 5 9 10 8 6 4 1 0
0 0 0 0 1 0 0 0 1 1 1 2 4 9 11 10 12 14 9 0
Histiocytic sarcoma
0 0 2 4 0 1 0 1 0 2 7 0 5 4 0 4 3 0 0 0
0 0 0 1 0 0 0 0 0 1 4 0 4 4 0 5 6 0 0 0
Squamous cell carcinoma in situ, NOS
0 3 13 1079 7336 13586 11898 7940 5328 3490 2551 2211 2100 2178 1727 1193 736 285 73 16
0 1 6 537 3978 7060 5857 3506 2395 1747 1471 1655 1951 2282 1948 1611 1493 1026 657 476
Oligodendroglioma, anaplastic
2 4 3 4 14 42 43 50 73 58 65 47 38 44 26 22 7 8 0 0
1 1 1 1 7 21 21 22 32 29 37 35 35 46 29 29 14 28 0 0
Squamous cell carcinoma, NOS
3 5 21 58 416 1377 2652 4332 7521 13395 21082 29855 37341 40985 38444 29706 17479 7697 2321 525
1 2 10 28 225 715 1305 1912 3381 6705 12157 22349 34704 42958 43373 40122 35479 27729 20902 15636
Sweat gland adenocarcinoma
0 0 1 1 3 10 8 8 18 25 25 31 43 34 52 37 35 19 14 5
0 0 0 0 1 5 3 3 8 12 14 23 39 35 58 49 71 68 126 148
Mast cell leukemia
0 0 0 0 2 1 1 0 1 0 0 1 2 0 1 0 1 0 0 0
0 0 0 0 1 0 0 0 0 0 0 0 1 0 1 0 2 0 0 0
Atypical chronic myeloid leuk., BCR/ABL negative
0 0 0 0 0 0 1 1 1 1 0 1 3 3 4 2 4 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 2 3 4 2 8 0 0 0
Follicular lymphoma, NOS
2 3 5 4 23 48 62 99 180 239 349 412 431 448 456 434 299 151 39 6
1 1 2 1 12 24 30 43 80 119 201 308 400 469 514 586 606 544 351 178
Collecting duct carcinoma
0 0 0 1 2 1 2 1 3 7 9 9 7 12 6 10 7 1 0 0
0 0 0 0 1 0 0 0 1 3 5 6 6 12 6 13 14 3 0 0
Chronic myeloid leukemia, NOS
51 30 56 116 195 325 449 556 562 606 721 789 905 1052 1093 1150 982 608 247 67
26 14 27 57 105 168 221 245 252 303 415 590 841 1102 1233 1553 1993 2190 2224 1995
Mucinous adenocarcinoma, endocervical type
0 0 0 0 0 0 2 5 3 5 7 6 3 1 1 2 1 0 0 0
0 0 0 0 0 0 0 2 1 2 4 4 2 1 1 2 2 0 0 0
Chronic myelomonocytic leukemia, NOS
3 0 0 1 2 7 7 17 16 21 46 62 136 220 331 371 377 227 79 11
1 0 0 0 1 3 3 7 7 10 26 46 126 230 373 501 765 817 711 327
Glassy cell carcinoma
0 0 0 1 0 0 0 3 2 0 1 0 0 2 0 0 1 1 0 0
0 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 2 3 0 0
Mixed type liposarcoma
0 0 0 0 1 3 7 10 15 16 12 16 13 17 13 10 13 1 1 0
0 0 0 0 0 1 3 4 6 8 6 11 12 17 14 13 26 3 9 0
Acinar cell cystadenocarcinoma
0 0 0 0 0 0 0 0 0 1 0 2 0 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0
Malignant tumor, small cell type
7 8 6 5 6 2 5 7 5 10 13 24 24 26 27 27 19 12 3 0
3 3 2 2 3 1 2 3 2 5 7 17 22 27 30 36 38 43 27 0
Basal cell carcinoma, nodular
0 0 0 0 0 0 1 0 0 0 2 4 2 4 6 9 9 4 5 0
0 0 0 0 0 0 0 0 0 0 1 2 1 4 6 12 18 14 45 0
Bronch.-alv. carc., mixed mucin. and non-mucinous
0 0 0 0 0 1 0 0 0 1 3 4 4 2 5 8 2 3 0 0
0 0 0 0 0 0 0 0 0 0 1 2 3 2 5 10 4 10 0 0
Squamous cell carcinoma, clear cell type
0 0 0 0 0 0 0 1 1 4 1 2 2 4 2 2 2 2 0 0
0 0 0 0 0 0 0 0 0 2 0 1 1 4 2 2 4 7 0 0
Malignant rhabdoid tumor
49 1 4 1 1 2 0 5 3 3 3 3 2 2 4 3 5 2 0 0
25 0 1 0 0 1 0 2 1 1 1 2 1 2 4 4 10 7 0 0
Enterochromaffin cell carcinoid
0 0 0 3 1 4 7 5 4 9 18 17 28 16 26 16 9 2 1 0
0 0 0 1 0 2 3 2 1 4 10 12 26 16 29 21 18 7 9 0
Basaloid carcinoma
0 0 0 0 0 0 3 9 13 13 51 55 57 73 66 52 46 30 3 3
0 0 0 0 0 0 1 3 5 6 29 41 52 76 74 70 93 108 27 89
Langerhans cell sarcoma
1 0 0 0 0 0 0 0 0 0 1 0 2 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0
Mullerian mixed tumor
0 1 0 3 3 6 23 33 65 89 180 305 444 492 550 439 360 165 54 10
0 0 0 1 1 3 11 14 29 44 103 228 412 515 620 592 730 594 486 297
Pilomatrix carcinoma
0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
Sq. cell carcinoma, keratinizing, NOS, in situ
0 0 0 6 28 63 78 58 39 36 19 30 36 32 23 21 8 8 1 0
0 0 0 2 15 32 38 25 17 18 10 22 33 33 25 28 16 28 9 0
Apocrine adenocarcinoma
0 0 0 2 0 6 11 25 48 44 73 74 94 91 98 105 73 30 15 4
0 0 0 0 0 3 5 11 21 22 42 55 87 95 110 141 148 108 135 119
Chordoma, NOS
3 4 14 17 21 17 28 45 31 49 58 57 50 73 65 47 31 17 8 1
1 1 6 8 11 8 13 19 13 24 33 42 46 76 73 63 62 61 72 29
Sq. cell carcinoma, keratinizing, NOS
1 0 0 7 47 151 373 592 936 1458 2013 2723 3242 3507 3425 2625 1607 794 261 65
0 0 0 3 25 78 183 261 420 729 1160 2038 3013 3675 3864 3545 3261 2860 2350 1935
Blue nevus, malignant
0 0 0 0 2 2 4 0 3 3 2 2 1 3 2 3 3 0 0 1
0 0 0 0 1 1 1 0 1 1 1 1 0 3 2 4 6 0 0 29
Neurilemoma, NOS
1 1 11 11 25 44 66 94 125 174 222 192 153 121 77 56 43 20 5 0
0 0 5 5 13 22 32 41 56 87 128 143 142 126 86 75 87 72 45 0
Follicular lymphoma, grade 2
0 0 1 6 21 57 108 204 340 471 582 689 704 750 765 678 444 195 44 9
0 0 0 2 11 29 53 90 152 235 335 515 654 786 863 915 901 702 396 268
Neurinomatosis
0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0
Juvenile myelomonocytic leukemia
17 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
8 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mucinous cystadenocarcinoma, non-invasive
0 0 0 1 1 2 3 4 5 1 1 2 4 1 4 2 1 0 0 0
0 0 0 0 0 1 1 1 2 0 0 1 3 1 4 2 2 0 0 0
Neurilemmoma, malignant
6 4 22 27 58 48 45 52 49 48 49 54 61 51 56 55 28 11 3 0
3 1 10 13 31 24 22 22 22 24 28 40 56 53 63 74 56 39 27 0
Mucinous cystadenocarcinoma, NOS
0 0 4 29 84 137 180 211 249 277 363 376 354 361 326 248 160 77 25 1
0 0 1 14 45 71 88 93 111 138 209 281 329 378 367 334 324 277 225 29
Malignant tumor, giant cell type
0 0 2 2 2 2 3 4 3 6 5 7 12 18 9 12 7 5 4 3
0 0 0 0 1 1 1 1 1 3 2 5 11 18 10 16 14 18 36 89
Adenocarcinoma with mixed subtypes
0 0 0 1 3 6 3 16 39 49 97 128 152 140 155 135 98 42 16 2
0 0 0 0 1 3 1 7 17 24 55 95 141 146 174 182 198 151 144 59
Therapy-related acute myeloid leukemia, NOS
0 1 1 1 1 0 1 2 4 5 1 8 3 6 3 4 3 3 0 0
0 0 0 0 0 0 0 0 1 2 0 5 2 6 3 5 6 10 0 0
Adenoid basal cell carcinoma
0 0 0 0 0 0 1 0 0 0 0 0 2 2 4 2 3 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 1 2 4 2 6 0 0 0
Ganglioglioma, NOS
13 11 19 15 9 14 6 8 10 3 4 1 1 0 0 0 0 1 0 0
6 5 9 7 4 7 2 3 4 1 2 0 0 0 0 0 0 3 0 0
Fibrous histiocytoma, malignant
18 19 32 86 89 117 170 203 262 317 357 480 569 650 746 719 622 345 145 31
9 9 15 42 48 60 83 89 117 158 205 359 528 681 841 971 1262 1242 1305 923
Giant cell tumor of bone, malignant
0 0 6 8 17 25 9 12 10 9 2 9 2 0 7 2 2 4 0 0
0 0 2 3 9 12 4 5 4 4 1 6 1 0 7 2 4 14 0 0
Teratoma, benign
1 1 1 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Clear cell sarcoma of kidney
30 6 0 0 1 1 1 1 1 1 2 2 3 1 3 0 2 0 0 0
15 2 0 0 0 0 0 0 0 0 1 1 2 1 3 0 4 0 0 0
Cloacogenic carcinoma
0 0 0 0 2 3 9 25 49 94 123 180 186 213 182 145 101 51 19 7
0 0 0 0 1 1 4 11 22 47 70 134 172 223 205 195 205 183 171 208
Ganglioglioma, anaplastic
1 2 2 5 2 3 2 1 0 2 1 2 1 0 0 1 0 0 0 0
0 0 0 2 1 1 0 0 0 1 0 1 0 0 0 1 0 0 0 0
Teratoma, NOS
0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interdigitating dendritic cell sarcoma
0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 2 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 4 0 0 0
Sq. cell carcinoma, lg. cell, non-ker., in situ
0 0 0 5 34 88 85 57 29 19 18 17 10 14 1 5 2 1 1 2
0 0 0 2 18 45 41 25 13 9 10 12 9 14 1 6 4 3 9 59
Chondroid chordoma
0 0 0 1 0 1 0 2 3 1 0 1 0 1 1 0 0 0 0 0
0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0
Mesodermal mixed tumor
0 0 0 1 1 0 2 5 13 26 33 76 129 151 138 112 66 35 10 1
0 0 0 0 0 0 0 2 5 13 19 56 119 158 155 151 133 126 90 29
Teratoma, malignant, NOS
152 34 93 181 228 211 168 95 38 28 16 8 6 11 5 7 4 1 0 0
79 16 45 90 123 109 82 41 17 14 9 5 5 11 5 9 8 3 0 0
Sq. cell carcinoma, lg. cell, non-ker.
0 0 1 5 35 225 376 472 610 659 718 909 994 1074 932 686 396 185 51 8
0 0 0 2 18 116 185 208 274 329 414 680 923 1125 1051 926 803 666 459 238
Nodular hidradenoma, malignant
0 1 0 2 2 1 2 3 7 9 8 5 12 22 17 9 15 8 7 1
0 0 0 0 1 0 0 1 3 4 4 3 11 23 19 12 30 28 63 29
Glioblastoma, NOS
40 70 92 105 170 244 340 556 907 1315 1968 2479 2760 2843 2817 2198 1248 457 127 11
20 34 45 52 92 126 167 245 407 658 1134 1855 2565 2979 3178 2968 2533 1646 1143 327
Nonencapsulated sclerosing carcinoma
0 0 1 3 7 11 17 12 15 19 28 16 10 12 8 6 6 0 0 0
0 0 0 1 3 5 8 5 6 9 16 11 9 12 9 8 12 0 0 0
Plasmacytoma, NOS
0 0 0 1 3 5 11 29 47 82 103 111 114 94 153 97 85 38 12 1
0 0 0 0 1 2 5 12 21 41 59 83 105 98 172 131 172 136 108 29
MPNST with rhabdomyoblastic differentiation
2 1 1 1 1 3 2 2 1 1 1 4 2 0 3 1 0 0 0 0
1 0 0 0 0 1 0 0 0 0 0 2 1 0 3 1 0 0 0 0
Papillary mucinous cystadenocarcinoma
0 0 0 4 11 21 32 24 24 43 56 50 43 41 63 40 18 12 2 2
0 0 0 1 5 10 15 10 10 21 32 37 39 42 71 54 36 43 18 59
Hemangioendothelioma, malignant
4 2 3 6 10 3 9 8 11 15 13 9 14 12 12 15 9 4 2 1
2 0 1 2 5 1 4 3 4 7 7 6 13 12 13 20 18 14 18 29
Comb. hepatocel. carcinoma & cholangiocarcinoma
0 0 1 1 0 1 5 2 9 20 30 19 48 47 39 39 21 5 0 1
0 0 0 0 0 0 2 0 4 10 17 14 44 49 44 52 42 18 0 29
Malignant tumor, spindle cell type
5 0 2 5 7 6 7 14 12 7 16 21 31 45 39 31 37 28 6 1
2 0 0 2 3 3 3 6 5 3 9 15 28 47 44 41 75 100 54 29
Centrol neurocytoma
0 0 1 5 3 4 6 7 3 2 1 0 0 2 0 1 0 0 0 0
0 0 0 2 1 2 2 3 1 1 0 0 0 2 0 1 0 0 0 0
Paget disease, mammary
0 0 0 0 0 1 5 20 24 49 45 68 66 77 77 74 50 39 30 6
0 0 0 0 0 0 2 8 10 24 25 50 61 80 86 99 101 140 270 178
Malignant giant cell tumor of soft parts
0 0 0 2 2 2 2 1 4 2 1 0 1 1 4 3 1 1 0 0
0 0 0 0 1 1 0 0 1 1 0 0 0 1 4 4 2 3 0 0
Goblet cell carcinoid
0 0 0 0 3 4 8 27 33 31 31 39 27 34 16 19 13 8 0 0
0 0 0 0 1 2 3 11 14 15 17 29 25 35 18 25 26 28 0 0
Pheochromocytoma
0 2 4 6 4 6 19 16 16 28 22 21 17 17 14 9 7 1 0 1
0 0 1 2 2 3 9 7 7 14 12 15 15 17 15 12 14 3 0 29
Follicular dendritic cell sarcoma
0 0 0 0 1 0 1 2 1 0 3 0 1 0 0 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0
Duct carcinoma in situ, solid type
0 0 0 0 0 4 14 51 168 225 303 286 213 207 159 172 100 40 6 4
0 0 0 0 0 2 6 22 75 112 174 214 197 216 179 232 202 144 54 119
Sq. cell carcinoma, sm. cell, non-ker.
0 0 0 0 0 8 11 12 16 23 21 32 38 43 48 34 14 2 2 0
0 0 0 0 0 4 5 5 7 11 12 23 35 45 54 45 28 7 18 0
Teratocarcinoma
6 4 22 210 460 416 286 148 76 48 18 8 10 11 4 2 0 2 0 1
3 1 10 104 249 216 140 65 34 24 10 5 9 11 4 2 0 7 0 29
Solid carcinoma, NOS
0 0 0 1 0 0 2 5 17 20 29 31 34 28 31 24 29 8 2 0
0 0 0 0 0 0 0 2 7 10 16 23 31 29 34 32 58 28 18 0
Dedifferentiated chordoma
0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Malignant eccrine spiradenoma
0 0 0 0 1 0 0 1 2 3 1 2 2 2 2 0 1 1 2 0
0 0 0 0 0 0 0 0 0 1 0 1 1 2 2 0 2 3 18 0
Giant cell glioblastoma
4 2 4 7 11 4 7 12 14 20 6 12 17 22 17 15 3 2 1 0
2 0 1 3 5 2 3 5 6 10 3 8 15 23 19 20 6 7 9 0
Capillary hemangioma
0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Multiple myeloma
0 1 0 1 10 34 110 321 712 1312 2324 3387 4390 5553 6099 5910 4449 2464 783 137
0 0 0 0 5 17 54 141 320 656 1340 2535 4080 5820 6881 7982 9030 8876 7051 4080
Acute promyelocytic leuk.,t(15;17)(q22;q11-12)
22 23 41 52 71 62 110 88 97 94 97 72 88 69 87 83 34 23 6 3
11 11 20 25 38 32 54 38 43 47 55 53 81 72 98 112 69 82 54 89
Mucinous cystic tumor of borderline malignancy (C56.9)
0 0 7 34 60 90 156 144 154 175 142 108 106 103 92 55 33 20 6 0
0 0 3 16 32 46 76 63 69 87 81 80 98 107 103 74 66 72 54 0
Aggressive NK-cell leukemia
0 0 0 1 0 1 0 1 0 0 0 3 3 2 0 3 0 1 0 0
0 0 0 0 0 0 0 0 0 0 0 2 2 2 0 4 0 3 0 0
ML, large B-cell, diffuse
32 58 138 322 500 776 1150 1503 1812 2127 2676 2942 3546 4333 5035 5068 3874 2173 789 141
16 28 67 160 271 403 566 663 814 1064 1543 2202 3295 4541 5680 6845 7863 7828 7105 4199
Dedifferentiated liposarcoma
0 0 1 0 0 2 6 12 15 18 33 24 35 47 48 35 32 12 0 1
0 0 0 0 0 1 2 5 6 9 19 17 32 49 54 47 64 43 0 29
Malignant tumor, clear cell type
0 1 0 0 0 0 0 0 0 1 0 1 1 2 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0
Paget dis. & infil. duct carcinoma
0 0 0 0 2 13 50 97 152 202 225 263 290 303 230 202 127 72 33 4
0 0 0 0 1 6 24 42 68 101 129 196 269 317 259 272 257 259 297 119
Brenner tumor, malignant
0 0 0 0 0 0 2 4 4 12 7 14 14 20 13 17 15 6 1 0
0 0 0 0 0 0 0 1 1 6 4 10 13 20 14 22 30 21 9 0
Acute myeloid leukemia, M6 type
11 2 5 3 7 11 8 15 21 21 45 65 97 113 111 114 102 58 13 2
5 0 2 1 3 5 3 6 9 10 25 48 90 118 125 153 207 208 117 59
Dermatofibrosarcoma, NOS
23 24 77 118 256 416 430 492 436 386 301 231 164 112 128 72 60 23 11 1
12 11 37 58 138 216 211 217 196 193 173 172 152 117 144 97 121 82 99 29
Malignant tenosynovial giant cell tumor
0 0 0 0 0 0 0 0 0 0 2 1 0 1 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0
Composite carcinoid
0 0 0 0 0 1 1 6 8 8 14 16 14 25 23 14 11 2 1 1
0 0 0 0 0 0 0 2 3 4 8 11 13 26 25 18 22 7 9 29
Malignant teratoma, undiff.
1 0 1 1 2 6 2 2 0 1 0 1 0 2 0 0 0 0 0 0
0 0 0 0 1 3 0 0 0 0 0 0 0 2 0 0 0 0 0 0
Carcinoma simplex
0 0 0 0 0 0 0 0 2 2 3 6 5 12 5 9 3 6 1 0
0 0 0 0 0 0 0 0 0 1 1 4 4 12 5 12 6 21 9 0
Sq. cell carcinoma, spindle cell
0 0 0 0 3 1 2 8 16 19 49 61 72 80 116 86 57 30 10 2
0 0 0 0 1 0 0 3 7 9 28 45 66 83 130 116 115 108 90 59
Gliofibroma
0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Choroid plexus papilloma, NOS
10 0 4 3 2 3 3 0 2 2 0 3 0 1 2 0 0 0 0 0
5 0 1 1 1 1 1 0 0 1 0 2 0 1 2 0 0 0 0 0
Mixed tumor, malignant, NOS
0 0 1 2 3 10 14 11 19 29 38 44 39 54 35 41 22 17 6 2
0 0 0 0 1 5 6 4 8 14 21 32 36 56 39 55 44 61 54 59
Gliosarcoma
0 0 1 2 1 3 8 9 15 23 30 32 39 38 51 34 21 2 1 0
0 0 0 0 0 1 3 3 6 11 17 23 36 39 57 45 42 7 9 0
Plasma cell leukemia
0 0 0 1 0 0 4 3 10 9 24 19 21 25 33 28 12 15 7 1
0 0 0 0 0 0 1 1 4 4 13 14 19 26 37 37 24 54 63 29
Atypical choroid plexus papilloma
0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mixed epithel. & spindle cell melanoma
1 2 2 5 9 14 13 23 24 52 70 70 71 101 82 74 50 24 11 1
0 0 0 2 4 7 6 10 10 26 40 52 65 105 92 99 101 86 99 29
Papillary mucinous cystadenoma, borderline malignancy (C56.9)
0 0 1 0 5 12 9 21 13 11 7 3 4 8 11 4 3 0 0 0
0 0 0 0 2 6 4 9 5 5 4 2 3 8 12 5 6 0 0 0
Plexiform neurofibroma
0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Acute myelomonocytic leukemia
30 13 24 29 41 57 62 65 97 102 107 140 194 214 272 252 235 100 49 15
15 6 11 14 22 29 30 28 43 51 61 104 180 224 306 340 477 360 441 446
Meningeal melanocytoma
0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Choroid plexus papilloma, malignant
32 4 4 0 2 3 2 2 2 0 4 4 2 0 0 0 0 0 1 0
16 1 1 0 1 1 0 0 0 0 2 2 1 0 0 0 0 0 9 0
Serous adenocarcinofibroma
0 0 0 0 0 0 0 1 0 1 1 1 3 2 1 1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 2 2 1 1 0 0 0 0
Meningeal melanomatosis
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Papillary serous cystadenocarcinoma
0 0 2 18 99 158 229 398 716 1156 1495 1856 2213 2098 1965 1699 981 420 91 18
0 0 0 8 53 82 112 175 321 578 862 1389 2056 2199 2216 2294 1991 1513 819 536
Paget disease, extramammary
0 0 0 0 0 1 0 4 12 15 28 59 104 121 142 164 122 70 13 5
0 0 0 0 0 0 0 1 5 7 16 44 96 126 160 221 247 252 117 148
Pigmented dermatofibrosarcoma protuberans
1 0 3 0 4 1 6 4 8 6 2 4 1 1 1 1 1 0 0 0
0 0 1 0 2 0 2 1 3 3 1 2 0 1 1 1 2 0 0 0
Acute megakaryoblastic leukemia
63 1 4 2 2 3 2 8 9 9 16 14 20 25 34 22 22 7 4 0
32 0 1 0 1 1 0 3 4 4 9 10 18 26 38 29 44 25 36 0
Atypical teratoid/rhabdoid tumor
23 0 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Adenocarcinoid tumor
0 0 2 2 11 9 15 20 39 42 26 45 26 25 33 25 10 11 2 0
0 0 0 0 5 4 7 8 17 21 14 33 24 26 37 33 20 39 18 0
Mesenchymal chondrosarcoma
0 4 8 9 18 8 10 6 8 11 6 3 6 5 7 3 0 0 0 0
0 1 3 4 9 4 4 2 3 5 3 2 5 5 7 4 0 0 0 0
